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Ion mobility-mass spectrometry measurement of proteins and multi-protein complexes is 
a tool of rapidly-growing importance in structural biology.  However, many challenges 
remain in its development, including: optimizing protein size/shape measurements, 
developing methods for protein-protein interface characterization, and constructing high-
throughput platforms for multiprotein topology determination. This thesis focuses on 
these challenges by developing new methods for ion mobility-mass spectrometry protein 
structure characterization. 
First, the performance characteristics of a second-generation travelling-wave ion mobility 
separator are assessed, focusing on those parameters that lead to the collection of high-
accuracy, high-precision measurements of protein size. The conditions for high accuracy 
protein size measurements are significantly different from those optimized for separation 
resolution, indicating that a balance between these two metrics must be attained for 
traveling wave ion mobility separations of biomolecules. 
Second, in order to enable the high-throughput structural analysis of protein complexes 
and their subcomplexes, ion mobility-mass spectrometry is coupled with automated 
robotic sampling of carefully-titrated solution conditions. By altering solution ionic 
strength in concert with dimethyl sulfoxide content, the data collected shows that simple 
two-dimensional solvent screens are sufficient to disrupt protein-protein interfaces for a 
xv 
 
broad array of complex structures and folds. Ion mobility measurements captured for 
both intact assemblies and subcomplexes matched expected values from available X-ray 
data in all cases save two, where extreme disruption conditions were employed. Strong 
correlations between the disruption agents and chemical nature of interfacial interactions 
are observed.   
A key challenge for protein ion mobility measurements of intact proteins is accessing 
local, domain-level structure information.  In a third set of experiments, gas-phase protein 
unfolding data were acquired for a range of monomeric proteins. The unfolding of multi-
domain proteins, using either collision-induced unfolding or Coulomb-associated 
stretching, revealed a strong, positive correlation with known protein domain structures 
in solution. 
In a final set of experiments, the protocols developed here using model protein systems 
are applied to two multiprotein complexes of currently unknown structure: the heme 
oxygenase-2/cytochrome P450 reductase dimer and the human mitochondrial 
ribonuclease P hetero-hexamer. In these cases, IM-MS aided by elucidating either the 




Chapter 1. Introduction 
Protein structures play key roles in protein functions. From primary sequence to 
quaternary structure, deviation at any level can cause malfunctions that lead to severe 
disease.1 Proteins rarely act in isolation, resulting in massive, dynamic multiprotein 
machines and networks that govern most critical cellular processes.2  As such, the 
structural characterization of these large-scale multi-component protein complexes has 
been a key goal of structural biology for decades.3  By the same token, protein complexes 
comprise most of the drug targets currently sought in treatment efforts for many human 
diseases. More recently, attention has turned to high-throughput technologies capable of 
assessing the structure and topology of many complexes in a serial fashion. The 
ambitious goals set in such studies include the structural annotation of large protein 
networks, thus enabling a three-dimensional view of vast webs of interacting proteins.4  
High-throughput versions of X-ray crystallography and nuclear magnetic resonance 
(NMR) spectroscopy have been important and pioneering tools in this process, and seek 
to directly convert isolated proteins and complexes into atomic-resolution representations 
of the interacting proteins involved in such networks (Figure 1-1).5  Such technologies 
currently dominate the landscape of structural genomics and proteomics research.  
While this direct approach has been highly successful for a large number of protein 
complexes and networks, the vast majority of multiprotein systems provide significant 
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challenges for X-ray and NMR-based approaches.  For example, although detection 
limits for both technologies continue to improve, relatively large amounts of protein are 
still required to acquire usable data.  In addition, as the complexity of the protein network 
under investigation increases, so do many parameters that complicate NMR and X-ray 
analysis, such as the increased presence of protein flexibility, heterogeneity, and 
polydispersity.3,5  These properties are found in abundance within membrane-associated 
protein complexes6 - a class of protein assemblies that are among the most-sought after as 
therapeutic targets.7  Further, since neither technology seeks to separate components 
during analysis, both require highly purified samples.  These and other challenges draw 
into dramatic relief the necessity for alternative approaches to solving multiprotein 
topology in a high-throughput framework.3,5,8 To supplement X-ray and NMR protein 
structure data, information from lower-resolution tools, with less-stringent sample 
requirements, are  complementary methods in structural analysis for protein complexes 
such as small angle X-Ray scattering (SAXS) or cryo-electron microscopy (cryo-EM),  
are frequently integrated to provide models of protein complexes. Rather than atomic 
details, these techniques focus on the shape, topology, and connectivity of interacting 
protein components8.  
Mass spectrometry (MS), and more-recently ion mobility-MS (IM-MS), of intact 
complexes is emerging as one of many such alternative approaches in the field of 
structural proteomics.3,5,9-15  In these experiments, an alternate route to a final high-
resolution map of the protein complex is sought, where protein connectivity and topology 
are defined in stages, prior to detailed homology modeling or partial atomic-resolution 
data is used to complete the process (Figure 1-1).16,17  For many years, MS technology, 
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driven by the needs of proteomics and other biology-related application areas, has been 
honed as a high-throughput methodology.  This makes MS a more obvious choice for 
high-throughput data production than many other tools capable of producing protein 
structure data. Further, MS of intact protein complexes has been highly successful in 
determining the details of protein-protein interaction within assemblies.14,18-20 Such two-
dimensional contact maps (Figure 1-1) are generated by exhaustive measurements of 
proteins and sub-complexes produced upon the disruption of intact assemblies.17,18,21 
Such disruption experiments can be carried out both in solution 21,22 and in the gas-
phase,23,24 and both approaches will be covered in some depth here. In this way, three-
dimensional models are built by integrating distance and size constraints from IM-MS 
measurements, along with other structural biology datasets and molecular modeling.16,25 
IM-MS, as the chief technology used to generate data in this thesis, will be discussed in 
detail, including topics such as: the evolution of IM-MS technology, data interpretation, 
methods of generating enhanced IM-MS data for protein complexes, and the integration 
of IM-MS with established proteomics protocols in efforts to define a structural picture of 
protein interaction networks.  IM-MS will also be discussed broadly in the context of the 




Figure 1-1 The challenge of structural genomics: converting protein interaction 
networks into protein structures.  
High-throughput structural genomics efforts currently underway rely heavily on 
technologies that can convert an isolated multi-protein complex directly into a structural 
model of atomic resolution (dashed grey arrow).  The stringent sample requirements 
involved result in relatively high failure-rates for such experiments.  An alternate 
approach (black arrows) uses MS data of intact complexes to generate a contact map, 
integrates IM data and other constraints to build a 3D topology model, and utilizes 
homology modeling or other forms of local constraint to generate the final atomic model 
for multi-protein complexes.  This IM-MS approach is projected to be a more-universal, 





1.1 Tools for Protein Structural Studies 
Besides mass spectrometry and related technologies, which will be covered in Chapter 
1.3 and throughout this thesis, mature structural tools like X-ray crystallography, NMR 
spectroscopy, cryo-electron microscopy. and small angle X-ray scattering have played 
key roles in protein structural studies. Combined, these techniques cover a broad scope of 
structural data, from atomic level detail to  multiprotein-scale size and shape, with each 
technology possessing unique advantages and shortcomings that drive their overall 
complementarity.  
X-ray crystallography is a method for determining the arrangement of atoms within a 
crystal using a beam of X-rays and their diffraction.26 A three-dimensional picture of the 
density of electrons within the crystal is derived from the angles and intensities of the 
diffracted X-rays, from which the mean positions of the atoms in the crystal can be 
determined, as well as protein interactions. Since the first high resolution structures of 
proteins were solved in the 1950s,27 X-ray crystallography has become the benchmark for 
protein structural analysis, accounting for  85% of the entries in the Protein Data Bank 
(PDB) (PDB, http://www.pdb.org/). Although this technique has developed significantly 
since its inception, from small molecules to intact ribosome complexes, many challenges 
remain, including membrane proteins, low-purity samples, and dynamic macromolecular 
machines.  
NMR spectroscopy works by aligning nuclei in a strong external magnetic field, and then 
uses an orthogonal pulsed magnetic field to measure the magnitude of nuclear magnetic 
moments, using deviations in the observed frequencies of their nuclear spins to deduce 
6 
 
atomic geometries.28 NMR approaches are frequently used to determine the structure and 
dynamics of protein structures in solution, in contrast to X-ray analyses, which are 
comprised of static structures. Each peak in an NMR spectrum represents a nucleus in a 
different chemical environment. One dimensional NMR can generate structural 
information for small proteins, however, for larger proteins, multi-dimensional NMR 
technologies are typically used to reach optimized resolution of nuclear spin states and 
connectivity.29  Examples of these approaches include transverse relaxation-optimized 
spectroscopy (TROSY)30 and isotope labeling approaches31. When a target protein binds 
to another protein or a ligand, changes in the chemical environment at the binding site 
can be observed by NMR.32,33 NMR protein analysis is typically frustrated by low 
concentration, low-purity samples containing very large protein complexes.3,5 
Cryo-EM analysis of large proteins and complexes  typically generates intermediate-
resolution structure information (~10 Å).34 This allows shape and topology definition to 
be obtained for large complexes in a native-like state. In a cryo-EM experiment, a beam 
of electrons is aimed at a flash-frozen sample in vitreous ice. Electrons scattered by 
protein samples in this manner can be converted into a two-dimensional image. Single-
particle analysis, as well as electron tomography with multiple tilted views of the same 
object, can reveal the shape and symmetry of an assembly.5 Following the construction of 
class average structures and average electron densities from EM data, individual proteins 
with known atomic structures can be docked and integrated into the determined 
topologies if the locations of individual chains are known. Although cryo-EM data are 
often obtained at a resolution of 10Å, several EM structures have been extended to 3.5Å 
resolution.35,36 While small proteins and samples of low purity still provide challenges for 
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EM analysis, the technology is able to provide structures of high-detail for a broad range 
of large, labile assemblies.37  
Finally, SAXS enables the determination of shapes of high-concentration, purified 
biopolymers in solution by measuring X-ray scattering patterns.38 Unlike crystal 
structures, SAXS collects the average signal over all protein conformations and 
orientations for molecules in solution, which results in lower resolution structure data.39 
Advantages of SAXS include the ability to analyze large protein complexes (as large as 
580 kDa) when compared to NMR, and avoids the damage associated with the high-
energy electrons used in cryo-EM.40  
1.2 Mass Spectrometry 
As discussed earlier, mass spectrometry (MS) and related technologies have provided 
dramatic insights into the composition and structure of multiprotein complexes. MS 
detects the mass to charge ratio (m/z) of an analyte after ionization. Structural approaches 
in MS are notable for their high sensitivity, unlimited mass range, high speed and high 
tolerance to sample impurities.13,14,41 The key components of MS often include ionization 
source, analyzer and a detector. Typical ionization sources used to analyze biological 
samples include electrospray ionization (ESI)42-44 and matrix-assisted laser desorption 
ionization (MALDI).45-47 The mass analyzer, the key component of MS, has evolved to 
include many devices that make use of a range of physical principles for m/z separation 
in time and space.  These include quadrupole (Q) filters.48,49  ion traps,50-52 time-of -flight 
(ToF),53,54  orbitrap,55-57 and Fourier transform ion cyclotron resonance (FTICR).58-60 
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Between the ionization source and the ultimate mass analyzer, many specialized 
components, tailored to enable different experimental needs, are typically mounted, and 
can include ion separators, guides, and additional mass filters.61-63 Only those 
components, ion sources and analyzers used during the prosecution of this thesis will be 
covered in detail below.  All data shown in this thesis are generated on a second-
generation Q-ToF instrument incorporating a traveling-wave IM separation device 
(Synapt G2, Waters, Milford, MA, USA) as shown in Figure 1-2.  
 
Figure 1-2 A schematic diagram of the Synapt G2, quadrupole-ion mobility-time-of-
flight mass spectrometry instrument used in these studies.  
(A) A general schematic of the complete instrument indicating the four main regions of 
instrument operation: ion generation (using a nESI ion source), ion selection (using a 
modified quadrupole mass analyzer capable of selecting ions up to 32,000 m/z), ion 
mobility separation (carried out in the tri-wave region described in detail in B), and ion 
mass analysis (using a time-of-flight mass analyzer capable of ~40,000 mass resolving 
power). (B) Detail is shown for the ion mobility separation, or tri-wave, region of the 
instrument. Three major traveling-wave (T-wave) ion guides dominate this section of the 
instrument, and include the ion trap (blue), ion mobility (purple), and the transfer (light 
red) regions. A fourth pressurized region is shown as the He cell (green), which facilitates 
the injections of ions across the pressure gradient that exists  between the ion trap and the 
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ion mobility regions with minimal ion activation. Typical mass flow controller values are 
also shown for the gas flow (in ml/min) into each enclosed region of the instrument. 
1.2.1 Electrospray Ionization (ESI) 
ESI is a soft ionization method used to produce gas phase ions for labile biomolecules.64 
In ESI, the analytes are present in a dilute solution and passed through a conductive 
emitter. An electric field is typically applied between the emitter outlet and a counter-
electrode. This high voltage causes charge accumulation at the emitter tip, forming a 
Taylor cone, which then works to aerosolize the solution into charged droplets at 
atmospheric pressure, typically assisted with gas flow and increased temperature. As the 
solvent within the aerosolized droplets evaporates, the Rayleigh charging limit is reached, 
prompting the droplets to fission into smaller droplets, eventually giving rise to charged 
analytes. 
Two mechanisms govern the ionization process for ESI. For smaller analytes, the ions are 
emitted directly from the droplet surface, typically described as the Ion Evaporation 
Model (IEM).65,66 While for larger analytes, like intact proteins, successive fission events 
result in a nano-scale droplet from which all solvent evaporates, leaving behind a charged 
analyte.67 This process is typically referred to as the Charge Residue Model (CRM).68 
ESI characteristically produces multiply-charged analytes, and minimal ion activation or 
fragmentation. ESI charging through a CRM mechanism is highly correlated with protein 
surface area.69 Typically, ESI sources use pressure-driven flow, with rates in the L /min 
range, utilizing emitter outlet sizes in the range of 50-100 m. Ion desolvation typically 
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requires the application of a drying gas and heating, and results in relatively low (<1%) 
ionization efficiencies.70  
To solve these problems, nano-electrospray ionization (nESI) was developed,71 using tip 
sizes of only 5-10 m. Flow rates for these devices are in the low nL/min range, thus 
generating small droplet sizes with no application of additional heat or drying gas, and 
resulting in higher (~10%) ionization efficiencies with lower potential voltages required 
for Taylor cone formation. The extremely low sample consumption makes nESI 
compatible with nano-scale LC.72 nESI also shows significantly improved sensitivity and 
higher tolerance to salts and other contaminants when compared to conventional ESI 
because of its ability to produce decreased initial droplets.73,74 Overall, nESI tends to 
provide ionziation and desolvation conditions that are conducive to maintaining fragile 
protein structures glycan structures73 and non-covalent protein complexes75,76 as 
discussed in section 1.3.1 and elsewhere in this thesis. 
1.2.2 Quadrupole Mass Filters 
Quadrupole filters consist of 2 pairs of parallel conductive rods positioned 
perpendicularly to each other. Alternating voltages (at RF frequencies), along with a DC 
voltage offset, is applied to each pair of rods. When the ions are traveling between the rod 
sets in the axial direction, they will oscillate longitudinally. Each combination of AC and 
DC voltages will only allow certain m/z values to pass through. Others will hit the rods 
before reaching the exit aperture. When operated in an RF-only mode, the rods act as an 
ion guide that pass all ions beyond certain m/z value determined by the RF amplitude 
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applied. A modified quadrupole mass filter is housed   in the Synapt G2 IM-MS system, 
capable of selecting ions up to 32,000 m/z. Increasing the quadrupole  m/z from typical 
values (<4,000), involves decreasing the operating RF frequency that drives the 
quadrupole rods.77,78 Selected ions can be subjected to collision induced dissociation 
(CID) or collision induced unfolding (CIU) following selection in the quadrupole. 
1.2.3 Time of Flight (ToF) Mass Analyzers 
ToF analyzers are popular due to their relatively high m/z resolution (>50,000 in high-
performance instruments), high mass accuracy (< 1ppm), high sensitivity, large dynamic 
range and fast (s) response times.53,79,80 When the ions enter the ToF source, they are 
subjected to an electric field designed to accelerate all ions. Thus, ions  of like charge, 
starting position and energy prior to acceleration will, upon exiting the ToF source, 
possess equal kinetic energies as defined in Equation 1.1 below:,  
                                             (1.1) 
where Ep is the electric field potential energy, z is the charge of the ion, U is the electric 
potential difference (voltage), Ek is the ion kinetic energy, m is the mass of the ion, and v 
is the ion velocity when exiting the electric field. With a fixed travel distance d, the time 
required for an accelerated ion to reach the ToF detector t can be determined by Equation 
1.2 below: 
√
                                                       (1.2) 
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In ToF MS, ion flight time is measured in an evacuated tube, and is used along with 
known values of d and U to enable the determination of ion m/z. One or two ion mirrors 
(reflectrons) can be used to double or quadruple the flight distance respectively, and 
correct for small differences in initial ion energy or position in the ToF source, in order to 
improve analyzer resolution. ToF is often coupled with IM in IM-MS instruments 
because of its fast response time, enabling many of ToF spectra to be acquired for a 
single IM peak.81-83 
1.3 Mass Spectrometry Study for Protein Structures and 
Interactions 
With soft ionization methods, fast measurements and versatile activation methods, MS 
has become an important tool in the characterization of many types of analytes.  MS, 
often in combination with complementary techniques, is capable of assigning protein 
complex connectivity, structural characteristics and interactions. There are several MS 
methods used in the analysis of multiprotein complexes. For example, MS of intact 
protein complexes, hydrogen-deuterium exchange (HDX), oxidative foot printing, and 
chemical cross-linking are all utilized in this context. IM, a relative new comer to the 
protein structure field and the focus of this thesis, will be discussed in detail in section 1.4. 
1.3.1 Mass Spectrometry of Intact Non-Covalent Protein Complexes 
By using soft ionization sources, mass spectrometry is able to analyze non-covalent 
interactions between proteins or protein and ligands in the gas phase. This allows 
complex stoichiometry, subunit connectivity and ligand specificity to be studied in 
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unprecedented detail. From the original observations of intact protein-ligand complexes 
by ESI-MS over twenty years ago, the mass and complexity range of the protein 
complexes that can be analyzed intact have increased exponentially, to include intact 
ribosomes (>2 MDa)84 and virus capsids (16 MDa)85. Affinity-based purification coupled 
to high-sensitivity MS detection has provided some of the clearest depictions of the 
macromolecular protein networks operating on the cellular level in terms of their 
connectivity, leading eventually to include sophisticated quantitative proteomics 
protocols.86,87 Dissociation techniques available, both in the gas phase and in solution , 
allow even further study of protein complex stoichiometry, subunit connectivity and 
ligand specificity.88 The fast response time of MS detection also enables the investigation 
of dynamic protein complex systems with high degrees of polydispersity, i.e. amyloid-
beta protein complexes.89 
1.3.2 Hydrogen-Deuterium Exchange (HDX) and Oxidative Foot-
Printing 
HDX and oxidative labeling are being used with increasing frequency prior to MS in 
order to assess dynamic structural changes within a host of multiprotein systems.90-94 
While the implementation of most MS experiments involves the proteolytic digestion of 
denatured proteins following the steps taken within the protocol to capture native protein-
protein contacts or structure information,95,96 HDX is frequently used to determine which 
parts of a protein are exposed to solvent and which are inaccessible due to of protein 
structure, folding or higher-order interactions.91,92,97,98 Labile hydrogens on the surface of 
proteins can be replaced with deuterium upon exposure to a D2O-containing solvent. 
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After a sample is incubated  in deuterated solvent for a specific amount of time, exchange 
is quenched by reducing solution pH and temperature, followed by proteolysis and 
analysis of the resulting peptides by chromatography coupled to MS. HDX-MS data 
analysis is typically challenging due to back-exchange and spectral complexity,99 but 
residue-level exchange levels can be quantified by using electron-based tandem MS 
technologies.100,101 Oxidative labeling, unlike HDX, generates highly stable labels 
through exposure of photons that excite water or hydrogen peroxide to create ·OH 
radicals, which then covalently modify protein surface residues.94,102,103 Then following 
proteolysis, separation, and MS analysis, protein interfaces and solvent exposure can be 
assessed by comparison with control samples. Like HDX-MS, oxidative footprinting 
experiments by MS are hampered by data interpretation and informatics challenges 
resulting from highly-complex labeling patterns, but residue level labeling can be 
assessed through modern tandem MS experiments.93,104  
1.3.3 Chemical Crosslinking 
Crosslinking protocols have been in use since the early 1950s.105 Crosslinking in 
combination with MS detection has increased in popularity over the past decade, both to 
study protein tertiary structure and protein-protein interactions.106-108 The crosslinkers, 
typically with the length between 10 to 20 Å, covalently link residues on protein chains 
that are within interaction distance with each other. Proteolytic digestion followed by MS 
is typically used to identify the increased mass associated with peptides having 
undergone the cross-linking reaction. Several modified peptide versions are possible, 
including those that contain un-reacted sites, dead-end cross-links, and completely cross-
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linked peptides.  This sample complexity, and the informatics challenges that result, 
present the greatest challenges associated with cross-linking data analysis by MS.  
Despite these challenges, chemical cross-linking has been extended to larger protein 
systems109-112 and in vivo measurements113,114 in recent years. 
1.4 IM-MS Technology 
Ion mobility (IM) separation, when coupled to MS, enables collection of protein complex 
size information, and when this is combined with the connectivity information described 
above, coarse-grained or atomic models of the assemblies can be constructed.88 In 
addition, IM-MS provides signal-to-noise, spectral deconvolution, and tandem MS 
benefits unique to the analysis of the multiply-charged protein complex ions produced by 
nESI.115 Following appropriate sample purification, separation, and ionization,18 IM 
separates protein ions based on their ability to traverse a chamber filled with inert 
neutrals under the influence of an electric field.  Larger protein ions undergo a greater 
number of collisions with the inert neutrals filling the chamber, and therefore have a 
larger collision cross section (CCS) than more compact protein ions of similar mass 
(Figure 1-3).116 While this description holds for most contemporary IM separations 
described currently in the literature, modern IM technology expands this basic principle 
into a variety of instrument platforms available for IM-MS experiments. Such 
instrumentation, as applied to multiprotein complexes, takes three basic forms: drift tube 
(DT)-type, differential mobility analyzer (DMA)-type, and travelling-wave (T-wave)-
type instruments.  All of these technologies have both strengths and weaknesses for the 
analysis of multiprotein assemblies.117,118 Other types of IM technology have yet to be 
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used in the analysis of proteins and their complexes, and as such, will not be discussed in 
detail here.  For example, high-field asymmetric waveform ion mobility spectrometry 
(FAIMS) and differential mobility spectrometry (DMS), separate ions based on observed 
differences in ion mobility as a function of separation field strength. 119,120,,121  While both 
are commercially available, it is currently not possible to use these technologies to 
reliably measure ion CCS. Consequently, FAIMS and DMS are typically not used in 
 
Figure 1-3 Ion mobility-mass spectrometry data acquisition and basic principles. 
Ions are generated at the ion source (lower left), and are allowed to drift in an ion guide
filled with neutral gas molecules under the influence of an electric field.  The ions
migrate through this region according to their size-to-charge ratio.  They are then injected
into a time-of-flight (ToF) mass analyzer under vacuum for mass-to-charge (m/z)
analysis.  The resulting data is 3-dimensional, containing ion intensity, size, and mass
information.  The various dimensions of the data can be shown as a contour plot (middle,
bottom), or 2D selections in drift time or m/z (lower right).  A key for the diagram is
shown, upper right. 
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experiments aimed at determining multiprotein structure. Other high-resolution IM 
technologies, such as overtone ion mobility spectrometry (OMS) 122,123 and cyclotron-
type drift tube analyzers124 have yet to be applied to large protein size measurement, but 
offer exciting opportunities for detailed IM measurements on such systems in the future. 
1.4.1 Drift –Tube (DT) 
Many of the first IM separations performed on intact proteins and small complexes were 
conducted using DT-type IM-MS instrumentation.118,125 DT-IMS measures ion CCS 
directly and provides high IMS resolving power in research-grade instruments. Such 
analyzers typically comprise a series of ring electrodes upon which a fixed axial gradient 
of the electric potential is constructed.  A direct proportionality between drift time and 
CCS is generally used to convert measurements into ion size information. While early 
versions of these devices suffered from significant ion losses and poor sensitivity when 
used for the analysis of biomolecules, contemporary implementations of the technology 
use ion guides either during or after IM separation in order to re-focus ions and preserve 
limits of detection.126-129  Furthermore, tandem DT analyzers have been used to assess 
micro-conformational states within the structural envelope of gas-phase protein ions, and 
have demonstrated that such structural populations can be stable on the millisecond 
timescale, thus enabling detailed assessments of gas-phase protein structure.130,131     
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1.4.2 Differential Mobility Analyzer (DMA) 
DMA-type analyzers have also been utilized to measure the size of a range of protein 
complexes.132  These devices function by introducing ions into a region filled with inert 
gas, often consisting of two plates having offset apertures for ion entrance and exit. A 
voltage is then scanned and the resulting ion trajectory between the entrance and exit 
aperture is dependent upon ion CCS.  In contrast to DT type IMS, which measures a size-
proportionate ion drift time, DMA analyzers measure the voltage required for ions to exit 
the analyzer and be transmitted for MS analysis. Ion mobility is inversely proportional to 
this voltage, and converting such information into ion CCS is typically performed 
through a rigorous calibration methodology.133,134 In an analogous fashion to quadrupole 
mass filters, DMA analyzers can ‘scan’ over all ion mobilities or ‘select’ and transmit 
ions having a narrow range of mobilites for more detailed analyses.118,134,135 In recent 
experiments, the proteins investigated using this technology have appeared more compact 
in the gas-phase than previously thought,133  although a detailed structural analysis of 
these data, and assessment of their broader implications, has yet to appear. Significant 
databases of protein size, as well as more-detailed treatments of multiprotein structure, 
have appeared based on DMA measurements,136-138 although many of these 
measurements are performed in the absence of MS measurements in tandem. 
1.4.3 Traveling-Wave (T-wave) 
The majority of IM-MS datasets for multiprotein complexes have been generated on IM-
MS instruments using T-wave IM analyzers.  T-wave IM analyzers are similar in basic 
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construction to DT-type IM devices, but differ significantly in their operation.  Rather 
than a linear field gradient, ions are propelled through the analyzer using a series of low-
voltage waves.77,139  Ions are carried by the waves relatively briefly before being 
subsumed by the wave front in a manner depending on the CCS of the ions being 
separated, generating a time-domain IM separation similar to DT-IM devices.140  An 
important feature of this process is that, due to the nature of the separation mechanism 
employed, T-wave drift times are most often calibrated using standard CCS values for 
protein complexes rather than calculated directly from drift time measurements.115  Apart 
from being the only IM analyzer currently incorporated into commercially available, 
high-sensitivity IM-MS instrumentation for ion size measurement in wide distribution, T-
wave analyzers offer some modest advantages in terms of separation resolution.141-143   
Often defined in terms of the centroid arrival time of the IM peak normalized to the IM 
peak width (t/t), drift time resolutions for DT analyzers range from 30-150 for research-
grade instruments, with those at the high end of the range produced using instruments 
with very long flight tubes (>1m) and high separation voltages (multiple kV).124,144,145  
Because of the physical principles involved in T-wave IM separation, drift time is 
correlated to CCS through an exponential relationship,115  which results in a T-wave drift 
time axis that is effectively ‘stretched’ relative to those achieved on DT analyzers.  This 
relationship enables T-wave separators to achieve 40-60 CCS resolution (CCS/CCS) 
using comparatively shorter devices, operating at lower fields and pressures, than DT 
devices of equivalent dimensions.142,143,146  
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The specific instrument involved used in this thesis is the Synapt G2 as shown in Figure 
1-2.142  Currently, two different instrument generations exist for Synapt instrumentation. 
The major differences between the first and second generation of the instrument are 
illustrated in Figure 1-4. The ‘tri-wave’ region of the instrument (Figure 1-2 B) consists 
of three main traveling-wave ion guide sections, enclosed from the main vacuum system, 
coupled to smaller traveling-wave ion guides that operate within the main vacuum system 
for increased conductance of the gas load within the enclosed regions of the instrument. 
This increased conductance between sections is an improvement over the first-generation 
instrument geometry. Subsequent to ion transport through the quadrupole mass analyzer, 
the initial traveling-wave ion guide encountered functions as an ion trap, where confining 
RF voltages act to contain the ions radially, and a DC gate field contains the ions axially. 
The first 9 cm of the device is enclosed and pressurized with argon gas to axialize the 
ions and store them prior to release into the next stage of the instrument. No traveling 
waves are active in this area of the instrument during ion trapping. After the gate field is 
released, the ions travel through a 4 cm traveling-wave ion guide to the next enclosed 




Figure 1-4 A schematic diagram illustrating key differences between the first and
second generations of Synapt instrumentation, focusing on the TW ion guides and
regions directly surrounding the TWIM separator.  
(A) Geometry for the ‘tri‐wave’ region of the first generation instrument, consisting of
three main TW ion guide sections: the ion trap region (blue), the TWIM separator
(purple), and the ion transfer region (green). The dashed waves shown in the ion trap TW
guide indicate that no traveling‐waves are active in this region during the ion trapping
portion of the instrument cycle. (B) Detailed view inside the first‐generation TWIM
separator. The total device is comprised of 122 ring electrodes (185 mm total length).
Each electrode is 0.5 mm thick, with 1.5 mm spacers inserted between electrodes. DC
pulses (traveling waves) are applied to the electrodes shown, with a 6 electrode pair
period for the overall waveform. A maximum of 30V can applied to electrode surfaces,
but only 60% of that applied voltage is experienced by ions in the center of the guide. (C)
A detailed view of the second generation TWIM region. The length of the device is
defined by 168 ring electrodes (254 mm total length), having equal dimensions to the
first‐generation device, but decreased spacing (1mm). In further contrast to the
first‐generation device, traveling waves are applied to 4 electrodes simultaneously and
are spaced by 4 electrodes. A maximum of 40 volts can be applied, and the improved
geometry allows for 90% of the applied voltage to be experienced by ions within the
guide. (D) Schematic diagram detailing the overall configuration of the traveling wave
ion guides within the second‐generation Synapt instrument. Key differences between this
design and the one shown in A include: decreased vacuum conductance in both the ion
trap and transfer regions, with regions of differential pumping installed (not shaded) and
a short ‘helium gate’ region (orange) which acts as a buffer between a higher pressure
TWIM separation region and the ion trap. 
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This short ‘helium gate’ region acts as a buffer between the IM separation region, which 
operates at high pressures of N2, and the ion trap, which operates at low pressures of Ar. 
The high pressures of He within this region of the instrument allow ions to be injected 
against a pressure gradient composed of a less-massive gas; and therefore, the ions 
experience less collisional activation and heating as a result of the process. In order to 
ensure that this region remains pressurized with primarily He, the pressures in the helium 
gate are typically kept at higher levels than IM travelling-wave region, resulting in IM 
separations carried out in a mixture of He and N2 gases on the Synapt G2. The 'helium 
gate' was not present in the first-generation version of the Synapt instrument and is a key 
difference between the two instrument geometries, allowing the IM separation region in 
the Synapt G2 to operate at higher pressures compared with the first-generation 
instrument. 
The IM separation region on the Synapt G2 is 25cm long (7cm longer than the first-
generation instrument), comprised of 168 plates, each 0.5mm thick and spaced by 1mm. 
Again, an RF field operates to compress the ions radially, while   traveling-waves drive 
the ions axially to perform ion mobility separation. In the first generation instrument, the 
traveling waves within this region were generated by applying the DC pulse to plate pairs, 
resulting in a narrow voltage wave capable of applying only 60% of the applied voltage.  
The Synapt G2 applies voltage to 4 plates simultaneously, resulting in a broader wave 
that sustains 90% of the voltage applied.   
After IM separation, the ions then encounter another short (4 cm) region of traveling-
wave ion guide that operates in the main vacuum system. Following this, a 9cm traveling-
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wave device, pressurized with the same Ar flow used for the ion trap region, is used to 
transfer the separation achieved in the IM separation region, without degradation, to the 
ToF analyzer for eventual m/z detection. The traveling-waves operating in this region are 
slow moving with relatively high amplitudes, and act to capture ions having undergone 
IM separation between waves to limit further diffusion and uncorrelated separation prior 
to MS analysis. Each enclosed region is connected to a gas-feed that is metered by a 
mass-flow controller calibrated for the gas utilized in each respective region of the 
instrument, and normal operating ranges for these controllers and recommended 
pressures are also shown in Figure 1-2 B and Figure 1-4 respectively, for each of the 
enclosed traveling-wave ion guide regions. 
1.5 IM-MS Data Interpretation 
Generating both protein contact and topology information from IM-MS data requires 
multiple levels of computational analysis.   
1.5.1 MS Data Analysis 
The first stage in this process is typically focused on the interpretation of MS data 
derived from both intact complexes and their constituent subcomplexes, as well as 
protein subunits generated through careful disruption of intact complexes. Obtaining an 
accurate component list of proteins within the complex, often from LC-MS protein 
identification experiments, is a critical, challenging stage in the analysis, as the mass 
measurement accuracy (MMA) achieved for intact proteins and complexes is often much 
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lower than those achieved for the peptide ions commonly encountered in ‘bottom-up’ 
proteomics experiments. This difference is primarily driven by the relative fragility and 
size of the multiprotein complex ions generated, thus limiting the extent of chemical 
purification and desolvation that can be used in their MS analysis.147,148  Often, the MMA 
achieved is due primarily to the level of desolvation achieved following nESI, with the 
peak widths and mass shifts recorded for complexes being directly correlated with the 
amount of non-volatile buffer material adhered to the assembly post-ionization.149,150  
Multiple software approaches have been developed for the automated mass analysis and 
deconvolution of nESI-MS datasets of protein complexes, enabling the interpretation of 
MS spectra containing multiple overlapping species in m/z, 148,151-153 and in compiling 
MS datasets to generate protein complex contact diagrams.  Further, recent advancements 
have been made in modeling the relative intensities within MS datasets in a more 
automated approach to spectral deconvolution.154 
1.5.2 IM Data Analysis 
In the interpretation of the IM data for multiprotein complexes, there are two main stages: 
the conversion of drift times into CCS values, and their comparison with model protein 
architectures.  The first stage in this two-step process is relatively straightforward for DT 
and DMA-type IM analyzers, which rely upon highly-robust calibration and simple 
algebraic relationships to convert primary data to ion sizes respectively.  T-wave 
analyzers, on the other hand, require careful calibration against standards having known 
CCS values in order to generate accurate results.115,155 Theoretical treatments of T-wave 
analyzers have indicated a quadradic relationship between drift time and ion CCS when 
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operated under a relatively narrow set of conditions.140 Experimental calibration 
relationships, however, give a range of exponential values for the drift time / CCS 
relationship, and thus must be determined experimentally during IM-MS data collection 
in order to achieve optimum accuracy.115,142  The accuracy of such measurements has 
increased dramatically in recent reports, owing primarily to the availability of a larger 
pool of available standards,155 such that modern T-wave CCS measurements are 
equivalent in accuracy and precision to those produced by other IM analyzers. While 
some reports have indicated that ions can be significantly heated during T-wave IM 
separation,156,157 recent results indicate that this effect, if present, does not influence CCS 
accuracy or precision on second-generation T-wave platforms.142   Following accurate 
CCS measurement, model structures are generated in silico and their CCS values are 
estimated computationally for comparison with experiment.  IM datasets recently 
published exhibit a broad correlation between known X-ray structures of complexes and 
the CCS values recorded for these same assemblies in the gas phase.11,158   While many 
approaches exist for estimating the CCS of X-ray and other structural models in silico 10, 
and relating the two datasets can be challenging,16 no computational approaches currently 
provide greater accuracy for multiprotein systems than simple, properly scaled, projection 
approximation (PA) calculations,158 and such estimates have been effectively used for a 
number of years to correlate IM measurements with trial multiprotein topologies.16,23,25 
Such methodologies are computationally inexpensive, and have the benefit of supporting 
coarse-grained protein representations for rapid modeling and topological prototyping. 
23,159   Scaling of such estimates is a key component of relating PA calculations to IM 
measurements, because without a properly tuned scaling factor such calculations 
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significantly mis-estimate the size of potential model structures.10  Recent computational 
results support the potential accuracy of scaled-PA estimates for the IM analysis of 
proteins and complexes, as well as introducing a new computational approach, termed the 
projection superposition approximation, or PSA, which features a tunable shape factor 
and retains much of the computational speed of PA calculations.160  
1.6 Optimizing the Information Content of IM-MS for 
Structural Proteomics 
 
The IM-MS protocols for structural proteomics described above rely heavily on 
measurements of intact protein complexes, as well as subcomplexes and subunits, for the 
determination of multiprotein topology.  Furthermore, proteins are typically represented 
in IM-MS derived models as spheroids unless additional information on the domain 
structure or fold of the protein is available from other sources that can be integrated with 
IM-MS constraints.  
1.6.1 Gas Phase Activation 
Early experiments relied heavily on tandem MS data, utilizing collision induced 
dissociation (CID), to disrupt protein complexes in the gas phase for the determination of 
complex stoichiometry.21  Recent CID experiments have revealed that the charge states of 
precursor ions selected for activation and dissociation can dramatically influence both the 
structure and identity of the product ions formed.  Precursor ions having charges 
unmodified from those produced from standard nESI conditions can occupy 
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intermediates having undergone both quaternary remodeling and monomer unfolding 
prior to dissociation.161-163  By contrast, charge reduced complexes subjected to CID can 
produce compact and presumably folded product ions.164  In rare cases, charge 
amplification has also been observed to enhance the folded character of product ions 
produced by multiprotein CID.165  Either extensive charge reduction or amplification, 
coupled with higher-energy CID, can result in the dissociation of covalent bonds within 
the complex to produce sequence informative peptide ions from protein termini.24,164  
This last observation suggests the exciting possibility of 'top down'-type protein 
identification experiments performed from multiprotein precursor ions, and has been 
duplicated using electron-mediated fragmentation approaches.166  Surface induced 
dissociation (SID) technology has recently emerged as an alternative to CID for 
multiprotein complexes, as it can generate subcomplex and presumably compact subunit 
product ions following multiprotein complex activation.167 Taken together with the 
important advances made recently in CID and electron-based fragmentation, gas-phase 
protein disruption approaches have the ability to access multiple levels of multiprotein 
organization to inform greatly protein contact map construction.   
Prior to dissociation, protein complexes typically unfold in the gas-phase upon collisional 
activation.23  The gas-phase unfolding of intact proteins is typically marked by a 
multitude of stable intermediate structures that, upon sufficient activation, give way to a 
string-like conformational state. By careful examination of such collision induced 
unfolding (CIU) patterns as a function of ion energy, protein stability, ligand-binding 
specificity and protein tertiary structures can be assessed.149,168-171  
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1.6.2 Solution Phase Disruption 
 
Figure 1-5 A high-throughput screening process to discover optimal solution
conditions for protein complex topology mapping by IM-MS.   
A two-dimensional screen is developed by varying the composition of solutions in a
stepwise fashion over several important variables (e.g., organic content).  Ions produced
from each solution state are then measured against basic figures of merit: MS resolving
power and mass accuracy (red), IM resolution and collision cross-section (blue), total ion
intensity (green), and the percentage of current that carries signal for subcomplexes or
monomeric proteins (purple). Optimal solutions for each of these classes of information
are identified and recorded.  In many cases, optimal solution conditions for each figure of
merit are mutually exclusive. 
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Despite the proliferation of gas-phase dissociation and disruption methodologies for 
multiprotein assemblies, such technologies often do not provide sufficient information on 
their own to deduce a complete protein network map.  As a complementary approach, 
those studies that have reported high-confidence level protein contact diagrams have 
optimized conditions in solution prior to nESI in order to generate subcomplexes having 
largely orthogonal compositions to those produced by the gas-phase methodologies 
described above. Such disruption experiments often involve small additions of organic 
solvent, alterations in ionic strength and solution pH in order to elicit the formation of 
topologically-informative subcomplexes.21,22,25,172,173 While the phenomenology of this 
process has been described in multiple reports, and early studies suggested that the 
evolutionary origins of the protein-protein interface structures within complexes can be 
used to predict disruption behavior,174,175  many of the basic principles at work during 
such multiprotein disruption experiments are still a matter of intense research. Therefore, 
a relatively exhaustive search of potential solution conditions for optimal disruption, 
performed in a trial-and-error manner, is usually necessary to develop the information 
necessary for protein contact map generation (Figure 1-5).  Protein disruption data are 
expected to correlate with the physical and chemical properties of the interacting 
interfaces between protein subunits. 174  Note that the optimal conditions for subcomplex 
generation may not overlap with those for other key figures of merit for IM-MS of intact 
protein complexes. This can result in losses in overall signal intensity, MS resolving 
power, and IM resolution during a search of solution conditions for subcomplex 
formation. While currently time consuming, such experiments have been critical in 
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establishing the assembly dynamics of viral coat proteins and assigning connectivity 
within multiple heteroprotein complexes of varying size and structure.25,176,177  
1.6.3 Protein Structure Stabilization 
In addition to actively destabilizing the structure and connectivity of protein complexes in 
both the gas-phase and in solution, stabilizing protein structures is an equally important 
goal of IM-MS protocols in structural proteomics.  Charge manipulation of protein 
complex ions produced by nESI, especially charge reduction, can be an effective method 
of protein stabilization in the gas-phase.   Recent work has indicated that charge 
reduction approaches that utilize gas-phase chemistries may be the most effective in the 
universal structural stabilization of multiprotein complexes.178 Similarly, small molecule 
additives can be used to influence evaporative cooling during nESI, and have been shown 
effective in stabilizing protein-ligand systems.179  Likewise, small molecules may be 
added in solution prior to nESI to stabilize the transition between solution and gas-phase 
for protein complexes.  Recent studies focused on Hofmeister-type salt systems have 
discovered dramatic variations between the stabilizing influences of different salts on 
gas-phase protein structure compared to solution.149,180  This work also fits into the 
solution-screening framework described above (Figure 1-5), where multiple salts and 
small molecules are titrated against IM measurements to gauge protein structural integrity 
for topology modeling. 
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1.7 Integrating Bottom-up Proteomics with Intact Protein IM-
MS 
Any effort made to structurally assess unknown protein networks by IM-MS incorporates 
a robust MS-based protein identification workflow in parallel.  Most IM-MS workflows 
for protein complex topology mapping from measurements of intact protein complexes 
have relied upon a complete list of interacting components, derived from 'bottom-up' and 
denatured protein-based 'top-down' type approaches for LC-MS protein identification. 
IM-MS technology also has a long history in both peptide mass mapping and automated 
LC-type protein identification experiments, which enables IM to contribute to protein 
component identification as well as protein structure assignment.181,182  By incorporating 
IM separation into standard LC-MS experimental workflows, peptide separation capacity 
can be increased by 1-2 orders of magnitude118,159,183-185 and highly-parallelized 
approaches to MS/MS can be implemented to increase sample throughput.186,187 If these 
advantages are coupled with the unique structure-based separations188,189 and chemical 
tagging methodologies that allow for different chemical classes to be distinguished based 
on the analysis of ‘trend-lines’ within IM-MS datasets,183 a compelling argument can be 
made for IM-MS workflows that cover both multiprotein interaction topology 
determination and protein identification.  MS experiments that have aimed to deduce 
protein contact diagrams for multiprotein complexes have incorporated extensive protein 
identification schemes into their published workflows (Figure 1-6).  Most of these 
involve partitioning samples into 2-3 tracks, where one track incorporates intact MS 
analysis of the complexes and sub-assemblies generated via disruption (see above), a 
second track uses ‘bottom-up’ proteomics to identify the proteins present in the mixture 
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via mass sequence tags and database searching, and a third (optional) track uses intact 
protein mass measurements on the denatured protein subunits to evaluate the level of 
post-translational modification present within the constituent proteins.  This last track can 
be critical to successful contact map generation, especially in cases where multiple 
subunits within the complex have similar sequence masses.  IM measurements on protein 
complexes have been incorporated into such workflows recently (Figure 1-6).  For 
example, IM measurements were used to determine the connectivity and topology of a 
trimeric protein subcomplex within the eIF3 heterocomplex.25  In these experiments, 
protein dimers that compose the trimer in question were observed for all but one of the 
possible pairs.  Such dimer signals could be absent from the MS measurements for many 
reasons, but IM measurements identified a linear arrangement of subunits which allowed 





Figure 1-6 A flow diagram for an integrated IM-MS structural proteomics 
workflow.   
After protein complex isolation via either standard affinity purification strategies, or
following over-expression and reconstitution of the complex in vitro (Grey box, top),
unknown protein samples are split into three channels.  One portion of the sample is
subjected to denaturation and enzymatic digestion for a combination of 'top-down' and
'bottom-up' type protein identification experiments.  These steps are critical for forming
an accurate component list for protein contact map generation.  A second sample fraction 
is submitted to MS for intact analysis, where the assembly is dissociated using a
combination of solution and gas-phase approaches to deduce protein connectivity.
Information from both of the above sample streams (green) is combined to assemble a
protein contact map.  A third sample fraction, using optimized solution conditions, is
submitted for IM analysis and measurement of protein size.  Ideally, this step can be
performed in parallel with MS analysis of the intact protein complex and subcomplexes
created by dissociation.  Size information on monomers is used to refine structures of the
subunits within in the complex, and various subcomplexes in a step-wise fashion.  A
cartoon showing how IM data can refine structures for both a multi-domain monomer
(purple) and a protein dimer (yellow/blue) are shown, and this information is combined
with MS-derived contact map information to provide a complete 3D protein topology
(red).   This information is then further combined with other sources of information or






IM-MS has, over the past several years, been used in a number of cases to determine the 
structures of aggregating peptide and protein systems,190-192 perform structural studies on 
a range of protein homo-oligomers,12,193 to establish the structural details of small hetero-
complexes,16 and to refine MS-derived contact maps for large hetero-assemblies.22   
These achievements have been driven equally by the advent of novel research-grade 
instruments and commercially-available IM-MS equipment optimized for the analysis of 
large protein assemblies.  In many cases, advances in instrumentation have provided 
increased IM resolution and MS resolving power.143   More importantly, modern 
instrumentation incorporates IM separation devices having high ion transmission 
efficiency, low limits of detection, that are capable of highly sensitive analyses.127,129,143 
It is clear that integrating IM separation into any MS workflow aimed at characterizing 
protein mixtures and interaction networks, in either a 'bottom-up' or 'top-down' paradigm, 
will substantially increase the information content of the resulting analysis.194     
While the outlook for IM-MS is generally positive, there are a number of challenges that 
limit its applicability in certain areas of proteomics. A number of these challenges are in 
the area of computational IM-MS data interpretation. While existing methodologies allow 
for model structures and experimental constraints to be compared relatively accurately, 
many sources of potential error still exist in such assessments.10 Appropriately-scaled 
versions of in silico estimates of model structure CCS values, for example, are relatively 
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accurate for currently studied protein complexes, however it is unknown if such 
approaches will continue to be accurate for the myriad of assembly structures predicted 
within the 3D proteome.  A potentially greater challenge for IM-MS computational data 
interpretation is the rapid and accurate generation of model structures from relatively 
limited primary information, or solely from IM-MS constraints.16  In the absence of X-
ray or NMR datasets, or when those datasets contain partial information only, algorithms 
for generating coarse-grained approximations of protein complex structure and topology 
must likely be substantially improved to begin assessing the structure of large hetero-
complexes in a high-throughput fashion.   
Experimental challenges for IM-MS measurements revolve around the ability to either 
stabilize protein structure in the absence of bulk solvent or to disrupt that structure to 
determine protein connectivity, substructure, and topology.  Furthermore, extending the 
IM-MS information content beyond subunit level resolution is another problem 
surrounding accurate topology construction. This challenge is amplified in experiments 
seeking to analyze protein complexes with multi-domains within each subunit. These 
protein subunits, often having flexible domains, typically require extra stabilization, and 
cannot be accurately modeled using single coarse-grain spheres.  
To overcome the challenges discussed above, several IM-MS experiments have been 
performed and are reported in this dissertation. This research is divided into 4 research-
related chapters aimed with presenting methods and data that circumvent some of the 
current limitations of IM-MS for protein complex structure analysis. 
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In chapter 2, the resolution and accuracy CCS measurements on the Synapt G2 are 
characterized for biomolecular ions, with the purpose of optimizing the instrument 
performance for accurate multiprotein topology construction. This chapter is published in 
the journal Analyst, 2011 136(17): 3534-41. 
In chapter 3, robotically-assisted titration is coupled to IM-MS to reveal the interface 
structures and analysis parameters critical for multiprotein topology mapping. A protocol 
for systematically searching for optimized solution conditions for protein-protein 
disruption is also presented. This chapter is in press in the journal Analytical Chemistry, 
2013, DOI: 10.1021/ac402276k 
In chapter 4, CIU and Coulombic unfolding of monomeric proteins is examined and 
correlated, for the first time, with protein domain structure in solution.  
Chapter 5 presents several datasets where the methods developed in Chapters 2-4 are 
applied to protein complexes with currently unknown architecture.  
In Chapter 6, conclusions and future directions of these newly developed tools for IM-
MS are discussed. 
The majority content in this introduction was published as a review on Expert Review of 
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Chapter 2. Characterizing the Resolution and 
Accuracy of a Second-Generation Traveling-
Wave Ion Mobility Separator for Biomolecular 
Ions 
2.1 Introduction 
Ion mobility (IM) separation is used extensively to assess the structure and identity of 
a large number of molecular analytes, ranging from atomic species1 to multiprotein 
complexes2,3 and viruses.4,5 The combination of this separation technology with mass 
spectrometry (IM-MS) has allowed more detailed and multi-dimensional analysis of 
both complex mixtures and biomolecules.6,7 Such hybrid IM-MS instruments have 
taken multiple forms, and recent advancements have seen improvements in both the 
IM and MS stages in modern instrumentation.8-11 Among these hybrid instruments, 
the quadrupole (Q)-IM-ToF MS instrument known as the Synapt HDMS system 
(Waters, Milford, MA, USA) uses a traveling-wave ion guide12 to perform IM 
separation (t/t ≈ 10-15), coupled to a high-performance time-of-flight MS (m/m ≈ 
20,000) and was released as the first commercial IM-MS platform in 2006.13 A 
second-generation version of this platform, the Synapt G2 HDMS was released in 
2009, and has demonstrated higher resolution and resolving powers in both the IM 
and MS dimensions.14 
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While many applications exist for IM-MS instrumentation, our group and others are 
interested in experiments aimed at determining the structure of multiprotein 
complexes.15,16 Multiple datasets acquired on first-generation Synapt instrumentation 
exist for a number of applications in this general area including: the overall 
assessment of multiprotein topology,17,18 the study of host-guest complexes,19 the 
characterization of protein-ligand complexes,20 and the refinement of small sections 
of multiprotein topology maps.21 In all of these cases, IM resolution, precision and 
accuracy are the key figures of merit that determine the extent to which IM separation 
can be used to refine the structure of biomolecules in a quantitative fashion. 
Currently, few reports exist detailing the application of the second-generation, higher-
performance Synapt G2 instrumentation to similar protein systems, but it is clear that 
defining the conditions and instrument settings that lead to the highest-precision, 
highest-accuracy IM-MS data on this platform will be crucial for applications in 
structural biology. 
The factors that influence IM resolution and accuracy have been the subject of 
detailed study for decades.22-24 For drift tube-type linear-field IM separators, the 
arrival time distribution of ions can be approximated by a modified Gaussian 
function, the total width of which (WT) depends upon broadening components from 
multiple sources: 
WT = WD + WSC + WP + WRXN + WC                                (2.1) 
Equation 2.1 describes the additive influence of diffusion (WD), space charge (WSC), 
initial pulse width (WP), reaction chemistry (WRXN), and any changes in conformation 
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that occur on a timescale faster than the IM separation performed (WC) on the total 
width of the recorded IM arrival time distributions for biomolecules. For cases where 
the WT can be approximated by WD alone, the resolution of IM (RDT) can be 
expressed as: 
                                     RDT =                 (2.2) 
where z is the ion charge, e is the charge on an electron, E is the field strength, L is 
the length of the drift tube, k is the Boltzmann constant, and T is drift tube 
temperature. Experimental evidence has shown that RDT can occupy values greater 
than 150 for instruments following conventional design practices,25 although such 
high RDT values have yet to be demonstrated for large biomolecules. The precision of 
IM measurements is often reported as a relative variance in collision cross-section 
(), the ultimate size information extracted from IM separations. Such variances can 
be as low as 1% and depend upon the reproducibility of the drift time measurement, 
and the ability to measure drift cell pressure and temperature accurately. 
Since traveling-wave ion mobility separators use time-varying potential ‘waves’ to 
drive ions through the drift tube, rather than a constant electric field, the resolution, 
precision, and accuracy achievable using such devices are defined differently. The 
instrumental factors that influence the resolution of traveling-wave IM separators 
(RTW) have been described from first-principles.
26 In cases where the width of the 
arrival time distribution is limited by diffusion alone, IM resolution is defined as: 
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                           RTW =      (2.3) 
where K is the ion mobility, [WH] is the wave amplitude or ‘wave height’ (in units of 
V), [WL] is the wave length, and [WV] is the wave velocity (in units of m/s). 
Therefore, theory predicts that RTW will increase with increasing K and [WH], and 
exhibit an inverse relationship to wave velocity [WV]; however, this relationship has 
yet to be rigorously tested experimentally. Due to the complex nature of ion drift in a 
traveling-wave IM separator, a calibration curve is typically constructed to convert 
ion drift times into  values,27 where  is related to traveling-wave drift time via an 
exponential function: 
     	A	 t,      (2.4) 
where tD
’ is traveling-wave drift time corrected for time spent outside the drift tube, z 
is the ion charge,  is the reduced mass of the ion-neutral collision complex, A is a 
fitting parameter, and X is the exponential calibration factor. Travelling-wave ion 
mobility data and theory currently indicate that the accuracy of this conversion 
greatly depends upon the calibration dataset and the instrument settings used for the 
calibration;26 however, the complete extent of potential variations in from 
traveling-wave IM measurements is currently unknown. Note also that the 
exponential relationship between tD and  leads to different effective resolution 
values when ions are considered in either drift time or collision cross-section space. 
For example, for a quadratic relationship between  and tD, the traveling wave  
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resolution ( ) would be twice the traveling wave resolution on a drift time axis 
.26	
In this study, we chart the resolution (in both drift time and collision cross-section 
space) and  accuracy of the second-generation traveling-wave ion mobility separator 
within the Synapt G2 platform. From these investigations, we are also able to 
generate general predictions regarding the  precision on this instrument platform. 
Our results indicate good agreement with theory and determine optimal conditions 
where maximum resolution and accuracy is achieved for biomolecules. We also 
briefly consider the issue of ion heating during the IM measurement, and find its 
influence on cross-section accuracy and IM resolution to be negligible for 
biomolecule measurements made on the second-generation platform utilized in these 
studies. 
2.2 Experimental  
2.2.1 Sample Preparation 
Peptide SDGRG (Sigma, S3771) and additional peptide mixture (5 M, Waters, 
186002337) were prepared in water/methanol/acetic acid (49/49/2) solutions. 
Cytochrome c (5 M, Sigma, C2506) was prepared in 200mM aqueous ammonium 
acetate solution, and then stored at -20oC. Protein complexes avidin (Sigma, A9275), 
alcohol dehydrogenase (ADH) (Sigma, A7011) and glutamate dehydrogenase (GDH) 
(Sigma, G7882) were solublized in 200 mM aqueous ammonium acetate solutions and 
50 
 
stored at -20 oC. The samples (10 M concentration of the complex) were then buffer-
exchanged using a Micro Bio-Spin 6 column (Bio-Rad, Hercules, CA) equilibrated 
with 200mM aqueous ammonium acetate just prior to IM-MS analysis.29  
2.2.2 Synapt G2 Instrumentation 
The second-generation Synapt platform has been described in some detail 
elsewhere,14 and its general layout and improvement has been discussed in Chapter 1 
in Figures 1-2 and 1-4. Although the instrument utilizes an upgraded ToF geometry 
with improved detection electronics as well as some additions to the ion source 
region, we will not discuss these aspects of the instrument in any detail here. The ‘tri-
wave’ region of the instrument consists of three main traveling-wave ion guide 
sections, enclosed from the main vacuum system, coupled to smaller traveling-wave 
ion guides that operate within the main vacuum system for increased conductance of 
the gas load within the enclosed regions of the instrument. This increased 
conductance between sections is an improvement over the first-generation instrument 
geometry. All data were collected using instrument settings on the Synapt G2 
designed to preserve fragile non-covalent interactions within protein structures and 
between protein-protein interactions. This typically involves elevated pressures in the 
source region (5-7 mbar), and decreasing all focusing voltages (e.g., cone, extractor, 
and bias voltages) to their minimum values for ion transmission.28 
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2.2.3 Data Collection and Analysis 
To investigate the influence of [WH], [WV] and pressure in the IM separation region 
(p) on IM resolution, all other instrument parameters are kept at constant values 
unless otherwise stated. For example, it was necessary to vary the operating pressure 
of the ion trap region of the instrument to achieve ion transmission for both peptides 
and large protein complexes under similar instrument settings (varied from 0 to 10 
mL/min Ar flow rate), and our experimental results indicate that altering this 
operating pressure has no influence on IM resolution or calibration. Typical tuning 
ranges are: [WH] = 16-40 V, [WV] = 150-2000 m/s and p = 1-4 mbar. The ion release 
time from the ion trap region can have a substantial influence on resolution, and was 
kept at a minimum value (< 200 s) for all experimental data reported here. When 
increasing the pressure of the IMS cell, we endeavored to keep the He/N2 constant in 
terms of gas flow rate, although only limited experiments have been performed so far 
to investigate optimum gas flow-rate ratios (Figure S.2-3). 
As with the experiments aimed at IM resolution, IM calibration experiments targeted 
the influence of [WH], [WV] and p on instrument performance. Calibration curves 
were generated using a previously-described protocol,27 and using literature  values 
derived for use with the Synapt instrument platform.29 Gaussian fitting was used to 
determine centroid drift time values for both standards and unknowns for the 
calibration results reported here. While we endeavored to keep all but the key 
experimental variables constant, some parameters were modified by small amounts to 
achieve ion transmission for calibration experiments in excess of those discussed 
52 
 
above. These included small variations to the helium cell DC bias, trap bias, and 
overall ToF record length. In all cases, such variations in instrument parameters were 
found to have no influence on IM calibration under the conditions reported here. 
2.3 Results and Discussion  
2.3.1 Trends in Drift Time Resolution on the Second-Generation 
Traveling-Wave Platform 
Equation 2.3 predicts that changes in both [WH] and [WV] will influence the  
recorded. In addition, since Equation 2.3 only applies under conditions where ions 
exposed to relatively low values of field-per-unit pressure (E/p), the increase in 
absolute drift tube pressure should also have an influence on IM separations, as its 
increase maximizes the total field strength that can be usefully applied to the ions. 
Therefore, we chose to track the resolution of IM separation on Synapt G2, as a 
function of the two traveling-wave associated parameters, [WH] and [WV], as well as 
the pressure in the IM separation region, p. Also, we surveyed a number of peptides, 
proteins and protein complexes in order to cover biomolecules with a range of K 




Figure 2-1 Charting the resolution of the second-generation traveling-wave ion
mobility separator on the Synapt G2.  
(A) A plot of wave height, [WH], versus traveling-wave drift time resolution , for
both the ADH tetramer (red squares) and the SDGRG pentapeptide (blue circles).  Data is
shown for two pressures, 4mBar (closed symbols) and 2mBar (open symbols). (B) A plot
of  versus traveling wave velocity, [WV]. Data is shown for ADH and SDGRG at
two pressures in the same manner as A. (C) A plot of the [WH] / [WV] ratio against the
fraction of maximum resolution achieved at a given [WH] at 4mbar. Data is shown for
ADH and SDGRG, and indicates that similar [WH] / [WV] ratios bring about maximum
 for both species (~0.1). The inset shown indicates the trend for the [WH] / [WV]
ratio as a function of pressure in the IM separator. (D) Contour plot charting the influence
of [WH] and [WV] on  (indicated on a color scale) for the SDGRG pentapeptide at 4
mBar pressure in the IM separator. (E) A contour plot similar for D, but for ADH
tetramer data. Similar [WH] and [WV] values provide optimum resolution for both ADH
and SDGRG ions. 
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Figure 2-1 shows several slices across the multi-dimensional datasets acquired, where 
the instrumental and sample-related variables described above were altered and RTW 
recorded. For the data shown in Figure 2-1, we focus on two ions having disparate K 
values: the SDGRG pentapeptide30 (490 Da, 1+) and alcohol dehydrogenase (ADH) 
tetramer ions (141 kDa, 24+) as snapshots of our current dataset. First, we examined 
the performance characteristics of IM separator at a given pressure by examining   
at a range of values of [WV] and [WH]. In Figure 2-1A, a plot of the maximum  
value achieved at any [WV] value is shown versus [WH]. The plot exhibits a positive 
correlation between the two parameters, as predicted by Equation 2.3 for both 
SDGRG pentapeptide and ADH tetramer ions. Note that the maximum  for the 
peptide is observed to exceed that of the protein complex under most [WH] values, 
also as predicted by Equation 2.3. We cannot, however, rule out the influence of 
enhanced conformational broadening for ADH ions relative to SDGRG ions (Wc, 
Equation 2.1) as a root cause of this observation. 
Figure 2-1B shows similar data where maximum  (for all [WH] values) is plotted 
against [WV]. Here again, the trend observed is in good agreement with that predicted 
by Equation 2.3. In addition, previously-reported numerical simulations of  show 
similar trends as a function of [WV].26 We interpret the observed decreases in  at 
the lowest [WV] values reported in Figure 2-1B as related to the greater proportion of 
ions carried with the traveling wave, rather than undergoing IM separation, under 
these conditions.  
In order to provide a metric for tuning the resolution of the traveling-wave device the 
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ratio between [WH] and [WV] was calculated and the maximum resolution afforded 
under the setting was estimated (Figure 2-1C). Since [WH] is positively-correlated 
with  at all [WV] (Figure 2-1A), the data shown in Figure 2-1C are normalized 
for its influence, and plotted on a relative resolution axis, expressed as a percent of 
the total resolution achieved at a given [WH] value. As with other datasets shown in 
Figure 2-1, p is held constant at 4mbar. The ideal value of [WH] / [WV] for both 
ADH and SDGRG centers on ~0.1, however the precise value changes slightly 
depending upon the wave height (e.g., between 0.088 and 0.13, Figure S.2-1). Much 
larger changes in the ideal [WH] / [WV] ratio for  are observed as a function of 
pressure in the IM separation region (inset, Figure 2-1C). Measured values of p 
ranging from 1 to 4 mBar provide ratios ranging from 0.025 to 0.1 for ADH tetramer 
ions, while much less variation is observed for SDGRG ions. 
A contour plot, showing the values of [WH] and [WV] that lead to optimum  for 
SDGRG at 4 mbar pressure in the IM separator, is shown in Figure 2-1D. Steep drop-
offs in  are observed at values of low [WH] and high [WV] (upper left, Figure 2-
1D). We also note that some areas on the plot shown, e.g., high [WH] and low [WV] 
do not provide either resolved IM data or ion transmission, and are shown on this plot 
for purposes of completeness only. The optimum ratio between [WH] and [WV], 
shown explicitly in Figure 2-1C, can also be observed in this data, as a curved area of 
high  values that extends from [WH] = 20, [WV] = 150 to [WH] = 40, [WV] = 




A similar three-dimensional plot is shown illustrating the influence of [WH] and 
[WV] on   for ADH tetramer ions.  Upon comparing Figures 2-1D and 2-1E, it is 
apparent that ADH ions can be transmitted and IM separated over a wider range of 
[WH] and [WV] values, and that the   recorded at many [WH] / [WV] ratios for 
ADH exceed those of the SDGRG pentapeptide. This trend is also observable in 
Figure 2-1A, where the 4 mBar dataset shows a cross-over point between the  
values of ADH and SDGRG at low [WH] values. The relative ‘flatness’ of the ADH 
 trends compared to those recorded for SDGRG is most-likely due to the 
substantially higher charge state of the ADH ions measured here (24+ versus 1+), 
leading to higher effective separation field strengths experienced for the tetramer ions 
at all [WH] values.  
2.3.2 Optimizing Conditions for Maximum Cross-section Accuracy 
The discussion above is limited to the factors that influence ; however, resolution 
is only one of several contributing factors to high quality IM-MS data. When IM drift 
times are converted to  values, a calibration curve is typically constructed from ion 
standards with known  values (Equation 2.4). The goodness of fit of this calibration 
curve to the experimental data, along with the error associated with the standards used 
and the reproducibility of the measurements is a contributing factor to the overall 
accuracy of  values reported from traveling-wave IM measurements. While previous 
protocols have suggested that maximizing the calibration curve correlation coefficient 
(R2) is a necessary step to achieve high-accuracy  values from traveling-wave drift 
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times, little data is currently available on what instrument parameters most-influence 
this critical metric of  accuracy.27 
Figure 2-2A shows a plot of [WV] versus R2 for approximately 100 calibration curves 
acquired under two separate pressure conditions, one at 4 mbar, and the other at 2 
mbar, recorded across [WH] ranging from 12 to 40 V. Peptide, protein, and 
multiprotein complex ions were used to construct the calibration curves for Figure 2-
2, and our calibration dataset also extends to both lower and higher pressures (Figure 
S.2-1). In general, we observe substantial decreases in R2, and also  accuracy, at 
both high [WV] values and lower pressures on the second-generation traveling wave 
IM separator on the Synapt G2. At 4 mBar, R2 remains relatively high across a broad 
[WV] range, and decreases to a value of 0.96 for calibration data collected over all 
Figure 2-2 The goodness of fit for calibration curves that allow for the conversion
between IM drift time measurements and collision cross-section accuracy depend
primarily upon wave velocity, and do not have a strong wave height dependence.  
(A) A plot of [WV], versus the correlation coefficient for calibration curves recorded for
two operating pressures for the IM separator. Decreased accuracy is observed at lower
pressure and higher [WV] values. (B) A 3Dplot of [WV], [WH] and calibration curve
correlation coefficient (R2).  Again, substantial differences in correlation are observed
only as a function of [WV], and not [WH]. 
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[WH] at [WV] = 1000. By contrast,  accuracy decreases more significantly at 2 
mBar, where only the lowest [WV] values provide suitable  accuracy for most IM-
MS applications. 
In order to investigate the influence of [WH] on R2 at all [WV] values, we constructed 
a three-dimensional plot shown in Figure 2-2B. Here, [WH] is plotted against [WV], 
in a similar fashion to Figures 2-1D and 2-1E, where R2 values are denoted by the 
color axis shown. In almost all cases, [WH] has no significant influence on the R2 
values determined for IM calibration curves. For example, for calibration curves 
determined at [WV] = 300, R2 values varied by less than 0.1%. Overall the data 
suggests that increased  accuracy can be achieved by operating the instrument at 
minimized [WV] values and at maximized pressures, in a fashion relatively 
independent of [WH] settings. 
2.3.3 The Influence of Ion Heating on Traveling Wave Resolution and 
Cross Section Accuracy 
The apparently independent nature of  accuracy as a function of [WH], the main 
driver in the maximum effective field strength that the ions experience during IM 
separation, led us to consider more closely the influence of ion heating in our dataset. 
If ions are thermally excited via energetic collisions with the neutral gas used for IM 
separation, structural transitions may occur, and degrade both accuracy and  
(by increasing Wc, Eqn. 1). Previous theoretical and experimental reports have 
discussed the potential of ion heating in the traveling-wave IM separation region.26,31 
59 
 
It is important to point out, however, that although ion heating may occur at some 
level during IM separation, threshold ion internal energies are required for 
biomolecules to undergo structural rearrangements that can be observed by IM. 
Therefore, increased ion temperature may not always lead to the decreases in IM data 
quality described above. 
In order to investigate the influence of ion heating on the accuracy of  values 
determined by travelling-wave IM drift time measurements, we selected 24+ ADH 
tetramer ions and treated them as ions with unknown  within our calibration 
Figure 2-3 Exploring the influence of ion heating on the accuracy of collision cross
section measurements using a traveling wave ion mobility device. 
(A) The collision-induced unfolding fingerprint for ADH ions, after having undergone
activation in the ion trap that precedes the IM separation region on the Synapt G2.  The
most compact form of ADH (white box) undergoes unfolding at significantly lower trap
collision voltages than other multiprotein complexes. (B) ADH  values are plotted as a
function of the [WV] used to acquire the data for two pressures, 2 mBar (red squares) and
4 mBar (blue circles). Data is shown using all [WH] values available at each [WV], and
the prediction interval for the fitted polynomial trend line is computed for each pressure
dataset (black dashed line). The inset shown plots the relative standard deviation () for
 recorded at all [WH] values at five selected [WV]. The average  as a function of




functions. The selection of ADH ions specifically was motivated by the data shown in 
Figure 2-3A, a collision induced unfolding (CIU) dataset for 24+ ADH tetramer ions, 
where an activating acceleration voltage in the ion trap prior to IM separation is 
increased and the drift time values occupied by intact tetramer are recorded. The 
intensity for each feature is represented on a color axis, similar to other 3D plots 
shown in this chapter. The most compact form of the ADH tetramer persists only until 
trap collision voltages exceed 15 V. This value is far less than those recorded for 
smaller peptides, proteins, and protein tetramers under similar conditions.32,33 
Therefore, as the ADH tetramer is prone to relatively facile gas-phase structural 
rearrangements as a function of ion heating, measurements of the  of the ion as a 
function of [WH] should reveal evidence of any adverse effects of activating 
collisions during IM separation on  accuracy for multiprotein systems. 
To test this hypothesis we measured  values were recorded for ADH tetramer ions 
as a function of [WV] over all [WH] values accessible at both 4 mBar and 2 mBar 
operating pressures in the IM separation (Figure 2-3B) region. Experimental  values 
decrease in our dataset relative to the known ADH  values, a type of transition not 
observed in Figure 2-3A. As observed in Figure 2-2, the primary driver of defects in 
 inaccuracy results from increasing [WV], not [WH]. The inset in Figure 2-3B 
illustrates this point, as do the prediction intervals for the fitted trends shown for the 
datasets in the main figure. Variations in  as a function of [WH] for ADH tetramers 
demonstrate a remarkably small amount of variation under the measurement and 
calibration conditions used here, with standard deviation ( values ranging from 
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0.1% to 0.3% across the whole dataset at all pressures (Figure 2-3B, Inset). Thus, our 
data suggests that ion heating is an insignificant factor in the  accuracy for ions 
measured here using second-generation traveling-wave instruments. Data shown in 
Figure 2-1A also illustrates that maximum  continually increases as a function of 
[WH] and, therefore, IM separation field strength, further indicating the lack of ion 
heating influence in our current dataset.  
2.3.4 Collision Cross-Section Resolution Compared with Drift Time 
Resolution for Traveling-Wave Instruments 
Because traveling-wave IM separators have an exponential relationship between 
measured drift time and collision cross-section, the resolution on a drift time axis, 
, does not equal the effective resolution of the separation on a collision cross-
section axis,  (Equation 2.4).  Since the calibration function is known to change 
as a function of [WV], [WH], and p, IM drift time data must be calibrated, and the 
exponential function is known to change as a function of [WV], [WH], and p, IM drift 
time data must be calibrated, and the exponential calibration factor, X, determined 
before  can be calculated.  Obviously, lower values of X are preferred, as they 
lead to higher overall  values.  Figure 2-4A plots X values determined for 
calibration curves determined at both 4 mBar and 2 mBar as a function of [WV] and 
at all accessible [WH] settings. The calibration function exponential factor is 
observed to decrease as a function of [WV] giving the lowest X factors at maximum 
[WV] for both pressures (Figure S.2-2). In addition, X decreases dramatically at lower 
pressures.  values are also shown in Figure 2-4A over the same [WV] range and 
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illustrate that while  is maximized at low [WV], the calibration curve X factors 
reaches its optimum (lower) values at larger [WV] values.   
By combining the recorded X factors and  through Equation 2.4, we have 
projected effective values of  for our data at 4 mBar and 2 mBar (Fig 2-4B, red 
data points), where both trends reach a maximum value of ~40 for ADH tetramer ions 
(maximum  under similar conditions was measured to be ~25). While  is 
maximized at low [WV] and high [WH], higher [WV] values at maximum [WH] is 
necessary to achieve maximum . However, as shown in Figure 2-2, and overlaid 
in Figure 2-4B (blue data points), the accuracy of the calibration curve decreases at 
higher [WV] and lower pressures. These conditions of minimum  accuracy 
correspond to those conditions where  is maximized. This observation, and the 
data shown in Figure 2-4B, frames a critical outcome of this work, in that it appears 
that a balance exists between maximizing  and optimizing  accuracy on 




Figure 2-4 Achieving optimum collision cross-section resolution. 
(A) A plot of drift time resolution for the traveling-wave (red squares) and calibration 
function exponential factor, X (blue circles) as a function of wave velocity, [WV]. While
 achieves maximum values at [WV] = 500, X achieves minimum values at the 
highest [WV] available. Two pressures are shown, 4 mbar (closed symbols) and 2 mbar
(open symbols), and decreased  and X are observed at lower pressures (B) By
combining  and X, we can project maximum  values as a function of [WV] (red
circles).  As expected, values are maximized at high [WV] values, where X is minimized. 
Somewhat surprisingly, lower pressures also display high	 , due to the lower X factor
under these conditions.  We also overlay a plot of ADH collision cross-section ()
accuracy in this plot to emphasize the point that optimal conditions for separating ions




The data presented here describes the first attempt to generate a working description 
of both collision cross-section resolution and accuracy and the instrumental factors 
that influence them on a traveling-wave ion mobility separation device. Four main 
conclusions can be drawn from our dataset. First, optimum  values are achieved 
at maximum values of p and [WH], but at intermediate values of [WV], where the 
ratio between [WH] and [WV] seems to be a useful value for determining the 
maximum  at all IM region pressures. Second, the collision cross-section 
accuracy, which is indicated by the correlation coefficient for the calibration curve 
used to convert between traveling-wave drift times and collision cross-section, tends 
to decrease at higher [WV] and at lower pressures. 
Thirdly, the accuracy we record is observed to be relatively invariant as a function 
of [WH], indicating that ion heating within the IM separation region does not drive 
conformational changes for biomolecules under the conditions reported here. Similar 
results were obtained for ,	 further indicating the lack of effective ion heating 
within the second-generation traveling-wave device. This conclusion stands in 
contrast to previous theoretical and experimental reports that indicated that such 
heating was both probable and capable of causing conformational transitions in a 
range of proteins and their complexes.26,31 It should be noted, however, that previous 
experimental data was acquired on a first-generation traveling-wave instrument that, 
while running at lower [WH] values, used substantially lower operating pressures 
within the IM separation region, leading to more-substantial maximum field strengths 
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encountered by ions undergoing IM separation. 
A final conclusion illustrates that while  is maximized at low [WV],  is 
maximized at higher [WV] as the exponential factor that determines the conversion 
between drift time and collision cross section is minimized. These observations frame 
an apparent balance between tuning the IM separator for either maximum  or 
maximum  accuracy. While the maximum value of  for multiprotein complexes 
reported here is ~40, values between 50 and 60  have been recorded in this study 
for peptide ions (Figure S.2-3). Surprisingly, operating the IM separation region at 
lower pressures, and thus driving X to lower values, leads to equivalent or superior 
 values when compared with experiments carried out at higher operating 
pressures (Figure 2-4B). We consider that differences in the composition of the gas 
within the IM separation region may account for these observations, and our 
continuing work in this area will test this hypothesis. 
Overall, the data presented here creates, for the first time, a formal description of the 
tuning parameters and protocols necessary for achieving high-accuracy and high-
resoltuion IM measurements on widely available commercial IM-MS instrumentation 
(e.g. Synapt G2). While the potential applications of the database presented here are 
broad, future work in our group will utilize the IM data presented here to achieve 
highly accurate and precise  values for protein and their complexes for generating 
topology models of multiprotein assemblies. 
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Figure S. 2-1 Traveling wave drift time resolution  versus [WH]/[WV], shown
at each [WH] measured. 
Although each [WH] gives different maximum , the ideal [WH]/[WV]s which give
the maximum  are similar across different [WH] (0.088-0.114 for SDGRG at 4mbar
(A)). Much larger changes in the ideal [WH]/[WV] ratio for  are observed as a
function of pressure in the IM separation region. As shown in the figures, ideal
[WH]/[WV] centers at ~0.1 for SDGRG at 4mbar (A) decreased to ~0.025 for SDGRG at






















Figure S. 2-2 Data for calibration curve exponential factor X 
 (A) A plot of [WV], versus the calibration function exponential X factor recorded for two 
operating pressures for the IM separator. (B) A 3D plot of [WV], [WH] and calibration 
function exponential X factor. Similar to calibration curve R2 (see details in main article), 
substantial differences in X factor are observed only as a function of wave velocity, not 
wave height. There is <1% difference across [WH] for both IMS pressure 4mbar and 



































Peptide m / Da Z ΩHe / Å
2 ΩN2 / Å
2 
RASG-1 1000.5 +2 225 331 
Angiotensin II 1045.5 +2 245 335 
 
 
Figure S. 2-3 Collision cross section resolution  of peptide ions at different 
pressures. 
Peptides RASG-1 and angiotensin II are separated under different pressures or gas 
compositions. (A) 1.98 mbar, (B) 3.86 mbar and (C) 3.93 mbar. All 3 data are taken 
under [WH]=40 V and [WV]=1000 m/s.  
Taking angiotensin II as example, the traveling wave drift time resolution  is 
calculated as 22, 27 and 29 for conditions in (A), (B) and (C) respectively. The higher 
 generated in (B) and (C) agrees with our conclusion that higher pressure is preferred 
for higher . However, with similar pressure, (B) and (C) resulted in significantly 
different drift time and thus different , which may indicate the influence of the gas 
composition on drift time resolution.  
Further, calibration function exponential X factor, 0.35, 0.45 and 0.5 for (A), (B) and (C) 
conditions respectively (extrapolated from calibration experiments discussed in the main 
article), is combined to convert the drift time resolution into collision cross section 
resolution . The calculated results are 58 for (A), 60 for (B) and 60 for (C). These 
values are higher than that achieved for ADH tetramer (~40) and further indicates that 
gas pressure and composition have little influence on	 . Instead, optimum values of 
[WH] and [WV] are most important. We note, however, as the pirani-type pressure gauge 
used in this region of the Synapt G2 is both not calibrated for He/N2 mixtures and 
relatively inaccurate, the IMS pressure values given must be treated as rough 
approximations only.  
He105 N2 35 2mbar 40+1000
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Chapter 3. Robotically-Assisted Titration 
Coupled to Ion Mobility-Mass Spectrometry 
Reveals the Interface Structures and Analysis 
Parameters Critical for Multiprotein Topology 
Mapping  
3.1 Introduction 
Proteins form most of the central macromolecular machines that support cellular life 
through the creation of dynamic multiprotein complexes.1 By the same token, such 
complexes comprise most of the important drug targets sought in treatment efforts for 
human disease.2,3   Due to their biochemical importance, broad efforts are currently 
underway to determine the structures of protein complexes on a proteome-wide scale.  
These efforts typically rely upon high-throughput X-ray crystallography and NMR 
protocols, with many other technologies operating in a supporting role to ensure high 
protein purity, stability, and concentrations.4,5  While this has been a very successful 
strategy, leading to the determination of many structures for large protein complexes, 
continued application of these basic approaches has also served to highlight their 
limitations.  For example, such experiments typically require the availability of a 
sufficient quantity of homogeneous material and significant method development efforts 
for success.6  These conditions are often difficult to meet and, thus, the number of 
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structures of multi-subunit protein complexes deposited in structural databases remains 
relatively low when compared to monomeric proteins.7 
Recently, technologies based on mass spectrometry (MS) have provided dramatic 
insights into the composition and structure of multiprotein complexes.8,9    Growing 
significantly from previous yeast two-hybrid screens,10 affinity-based purification 
coupled to MS detection has provided some of clearest depictions of macromolecular 
protein networks in terms of their connectivity,11  leading eventually to include 
sophisticated quantitative proteomics protocols.11   Chemical cross linking (CXL) in 
conjunction with MS experiments also have expanded our knowledge of both global 
protein networks and individual macromolecular protein complexes.11,12    Hydrogen-
deuterium exchange (HDX) and oxidative labeling are being used with increasing 
frequency prior to MS in order to assess dynamic structural changes within a host of 
multiprotein systems.13-15    While the implementation of most MS experiments involve 
the proteolytic digestion of denatured proteins following the steps taken within the 
protocol to capture native protein-protein contact or structure information,16  MS 
experiments that introduce intact protein complexes directly into the instrument can also 
be used to provide, in many cases, a greater amount of native structure information.17   
Despite the challenges inherent in analyzing large protein ions by MS, such experiments 
have aided in the development of protein structure models for a range of complexes in 
advance of more-conventional structural biology approaches.17-19    
While such MS measurements rely principally upon preserving an entire multiprotein 
assembly during both sample preparation and detection,20  recent experiments in this area 
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have highlighted the utility of partially disrupting the protein-protein contacts within 
complexes so that various subcomplexes are also detected during the experiment.19,21,22   
Such disruption steps enable the determination of protein complex connectivity and 
stoichiometry to a level of detail that few other approaches can match.23,24    Typically, 
two separate and complementary approaches for subcomplex formation are pursued: gas-
phase activation and solution-phase disruption.21,25-28   The former most-often utilizes 
collisional activation of gas-phase ions to initiate dissociation, forming individual protein 
subunit and stripped protein complex product ions.25,29,30   While an indispensible tool for 
verifying protein connectivity and stoichiometry, larger subcomplexes are typically not 
formed in the unimolecular decay reactions that proceed during collision induced 
dissociation (CID) of multiprotein complex ions, thus somewhat limiting the overall 
utility of the technique in the context of protein structure modeling efforts.19   Charge 
manipulation in combination with collisional activation, as well as alterative activation 
methods, have shown promise in altering the overall mechanism of protein complex CID 
to realize increased information content.31   Current practice, however, dictates significant 
solution-phase protein complex disruption efforts in order to generate sufficient 
information to fully-define protein topology and connectivity by intact MS methods.32   
Such disruption is often initiated by altering solvent composition, pH and ionic strength 
to favor protein subcomplex formation.32   The subcomplexes formed in such 
experiments have been shown to reflect the known organizational substructure of 
complexes,21,22,33 and when combined with CID, can be used to deduce a complete 
organizational diagram of protein complexes of previously unknown structure.34  
However, conditions that optimize the ion signal recorded for protein subcomplexes are 
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often found through a time consuming, trial-and-error based process that can substantially 
limit the throughput of MS experiments. 
Ion mobility (IM) separation,35  when coupled to MS, enables the collection of protein 
complex size information, and when this is combined with the connectivity information 
described above, coarse-grained (CG) or atomic models of the assemblies can be 
constructed.32,36 In addition, IM-MS provides signal-to-noise, spectral deconvolution, and 
tandem MS benefits unique to the analysis of the multiply-charged protein complex ions 
produced by nESI.37     Specifically, IM-MS was used to refine a connectivity model for 
the eukaryotic ribosomal initiation factor 3 complex,22  provided key structural data for 
models of rotary adenosine triphosphatases/synthases,38 pallindromic repeat-associated 
protein complexes,39  and utilized to deduce complete models for B-crystallin40 and 
DNA replisome assemblies.41   In addition, models for the highly-dynamic olgiomers 
involved in the amyloid-,42 norwalk virus,43 and -2 microglobulin44 
aggregation/assembly pathways have been constructed using IM-MS. In every case, IM 
measurements of many inter-related protein complexes, connected either through 
assembly, equilibrium, or intentional disruption, were used to construct the resultant 
models.  Key assumptions surrounding such IM-MS derived models include:  a strong 
relationship between subcomplex and higher-order assembly quaternary structure, a high 
degree of structural correlation between gas-phase and native state proteins, and a lack of 
significant protein subunit conformation changes upon higher-order complex formation 
or disruption.  While most IM-MS models have been cross-validated using other 
structural biology tools and control samples,22,39,40 there are many foundational questions 
that still surround the use of subcomplex information as a constraint for larger related 
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oligomers, especially when ideal disruption conditions introduce significant amounts of 
potential chemical denaturants in solution. 
Here, we couple automated titration and nESI of protein complex samples to IM-MS in 
order to deduce the optimum protocols and analysis guidelines necessary for high-
throughput protein topology mapping experiments. Our total dataset contains ca. 400 
individual IM-MS datasets, thus necessitating an automated approach.  We discover that 
IM-MS measurements of intact multiprotein complexes and subcomplexes can be readily 
mapped onto known solution structures, with few exceptions.  For those exceptions, the 
distortion of subcomplexes is mirrored in distorted intact complexes, which are also 
detected by IM-MS.  We find strong correlations between the disruption of intact 
complexes with specific reagents and quantitative values for the different classes of 
interactions that form the protein-protein interfaces within the intact assembly. We 
propose that such information can be used in the future to deduce the critical contacts 
within unknown complexes, and project the utility of IM-MS in structural proteomics and 
genomics efforts broadly in light of the data presented. 
 
3.2 Experimental 
3.2.1 Sample Preparation 
Homo-tetrameric protein complexes studied included transthyretin (TTR, human, Sigma 
P1742), avidin (AVD, egg white, Sigma A9275), concanavalin A (CON, jack bean, 
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Sigma C2010), alcohol dehydrogenase (ADH, Saccharomyces cerevisiae, Sigma A7011), 
aldolase (ALD, rabbit muscle, Sigma A2714), pyruvate kinase (PKI, rabbit muscle, 
Sigma P9136), catalase (CAT, bovine liver, CalBioChem 219001) and β-galactosidase 
(βGL, E.coli, Sigma G5635). Standards used to construct collision cross-section (CCS) 
calibration curves include: a mixture of peptides (Waters, product code: 186002337), 
monomeric cytochrome C (Sigma, C2506), and the protein complexes AVD, CON, 
ADH, and glutamate dehydrogenase (GDH) (Sigma, G7882). All protein complexes were 
solubilized in 200 mM aqueous ammonium acetate (NH4Ac) solutions and stored at -80 
. Stock samples (50 µM with respect to the complex, diluted 10 fold afterwards) were 
then buffer-exchanged just prior to disruption experiments and IM-MS analysis, using a 
Micro Bio-Spin 30 column (Bio-Rad, Hercules, CA) equilibrated with 200 mM aqueous 
NH4Ac. While the final concentration of protein complexes is unknown, control 
experiments performed with the protein complexes studied here over a range of 
concentrations (as low as 3 M) did not alter the oligomeric states detected. The peptide 
mixture (~2 µM for each peptide) was prepared in a water/methanol/ acetic acid (49/49/2) 
solution. Stock cytochrome C (5 µM) was prepared in 200 mM aqueous NH4Ac, and 
stored at -80 . 
3.2.2 Ion Mobility-Mass Spectrometry 
Solution composition screens for subcomplex formation were performed using an 
automatable, chip-based nano-electrospray (nESI) robot, (TriVersa NanoMate, Advion, 
Ithaca NY), capable of both rapid sampling and mixing. Solution parameters were 
screened in a two-dimensional fashion to be compatible with robotic sampling of a 96-
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well plate. An Advanced User Interface (AUI) module in the control software allowed 
programmed sequential aspiration, and allowed for protein samples to be quickly 
dispensed into individual wells and mixed with disrupting agents under highly-controlled 
temperatures (18 °C). After mixing, chip-based nESI using nano-machined emitters (5 
m) was initiated through the robotic sampling of individual solutions with conductive 
pipette tips. In general, samples were sprayed immediately after mixing, however, 
various incubation times were tested for selected protein complexes (e.g., AVD), ranging 
from  minutes to hours, and resulted in no significant change in disruption behavior. Chip 
based emitters were maintained at 1.3 kV to 1.9 kV.  Samples prepared at high ionic 
strengths or solutions containing large amounts of organic co-solvent generally required 
lower nESI voltages and higher backing pressures (0.1-1 psi) to avoid salt cluster-related 
chemical noise and generate stable spray conditions respectively.  
IM-MS data were acquired on a Synapt G2 (Waters, Milford, MA) 45 optimized for the 
study of large multiprotein complexes, as described previously.46 For the purposes of 
topology construction, the accuracy of CCS measurements for both intact protein 
complexes and dissociated products was optimized through highly linear CCS calibration 
curves (R2 > 0.98), resulting from high pressure (3-4 mbar), low wave height (12-15 V) 
and low wave velocity (150-200 m/s) travelling wave IM conditions.46  Initial IM-MS 
Data processing was performed using Masslynx v4.1, Driftscope v2.0 (both from Waters, 
Milford, MA), as well as previously-described IM calibration tools.37,47 
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3.2.3 X-ray and IM Data Comparisons and Computational Analysis 
Coarse-grained (CG) topology models for the protein tetramers discussed in this chapter 
were constructed either using a simple symmetry analysis of X-ray structures using in-
house python scripts and visualized in PyMol, or using IM-derived CCSs as described 
below. Protein data bank (PDB) IDs for the X-ray structures used here are given in 
Supplemental Information. All model structures were evaluated in terms of their 
agreement with IM data using a version of the program Mobcal modified for the analysis 
of coarse grained structures.37  For all model CCS values, a scaled version of the 
projection approximation (PA) found in Mobcal was used,48 as such methods have 
exhibited strong, broad agreement with experimental IM-MS data.49 For model 
topologies constructed using IM data, the size of a single sphere was constrained using 
monomer CCS data. Then, the distance between monomer units was constrained using 
protein dimer CCS values.  Finally, a dimer-dimer distance was constrained using 
tetramer CCS measurements. The final IM-based model was then compared to the same 
CG values derived from the X-ray structure. Note that not all tetramers studied in this 
chapter are planar, and that the above protocol does not evaluate the relative angles 
between protein subunits.33,41 To resolve a planar tetramer geometry from that of a 
tetrahedral structure, an IM CCS resolution in excess of 100 has been projected to be 
necessary for protein complexes comprised of >10 kDa subunits, whereas the maximum 
CCS resolution recorded to-date on the Synapt G2 is 50-60.37,46  A number of quantitative 
values related to protein structure were extracted from X-ray and IM-MS data, and 
compared.  These values are defined in detail in Supplemental Information. 
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3.3 Results and Discussion 
Figure 3-1 IM-MS data collection 
and analysis procedures.  
(A) Disrupting agents and protein
complexes are mixed in solvents
containing either increased amounts
of organic (DMSO, red) or salt
(NH4Ac, blue). (B) Each sample is
sprayed using a chip-based nESI 
emitter array. (C) An example
overlay of two IM-MS plots under
high organic (red) and high salt
(blue) conditions respectively. (D)
IM-based size measurements
recovered for both intact complexes
and subcomplexes as a function of
charge state (green and yellow for
different charge states). (E & F)
Protein sizes are converted to
distance constraints, and tested
against those calculated from X-ray.
(G) Signal intensities recorded for
intact complex ions are plotted
against the amount of disrupting
agent added in solution. (H & I)
These data are analyzed with respect
to the separate interaction types
found within the protein-protein
interfaces from X-ray. 
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Figure 3-1 illustrates the experimental protocol used in this study. Protein complex 
sample was partitioned into a 96-well plate where different amounts of disrupting agents 
were robotically added into the existing aqueous solutions (Figure 3-1A). The amounts of 
these agents were then modified in a stepwise fashion across one axis of the plate.  For 
the complexes studied here, we found that a two-component screen, that varied the 
DMSO (red wells, Figure 3-1A) and NH4Ac (blue wells, Figure 3-1A) content of the 
protein complex-containing solutions was sufficient to disrupt and interrogate all eight 
protein tetramers, while keeping the total protein concentration constant (5M). Solutions 
contained, at most, 67% DMSO by volume and 4M NH4Ac, beyond which significant 
protein secondary structure changes may occur.50 Following the addition of disruption 
agents, samples were then immediately sprayed through one of the nozzles on a nESI 
chip (Figure 3-1B). IM-MS data were then recorded (Figure 3-1C), and subtle changes in 
protein oligomeric state, CCS, and charge state were detected. As observed 
previously,18,23 the sub-assemblies observed under disruption conditions reflect the 
known sub-structure of the intact complexes analyzed.  All complexes studied here are 
tetramers comprised of dimeric subcomplexes, possessed of non-covalent bonds of 
varying strengths.  By quantifying the sizes of the subcomplexes observed by IM-MS 
(Figure 3-1D) over a range of charge states, CG models of the relative interface sizes 
within these tetramers were constructed (Figure 3-1E) and compared against X-ray 
datasets (Figure 3-1F) to detect correlations. In parallel with this analysis track, the 
relative intensities of the subcomplexes were recorded (Figure 3-1G) and correlated to the 
influence of specific disrupting agents likely to disproportionately influence selected sub-
classes of protein-protein contacts (Figure 3-1H).  These data were then also correlated 
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with X-ray data where specific interactions were precisely measured (Figure 3-1I), 
allowing us to evaluate the ability of IM-MS to quantify the type of interactions present 
within unknown protein-protein interfaces.  
3.3.1 Evaluating the Fidelity of IM-MS Derived Protein Topology 
 
 
Figure 3-2 Evaluating the fidelity of
IM-MS derived protein topology. 
(A) A plot of R values generated from
IM-MS data vs. R values from X-ray
structures for eight protein tetramers.
Color-coded bands indicate the range of
R values recovered from IM-MS data,
and black bands represent the average.
The solid line represents a 1:1 
correlation between the IM-MS
experiment and X-ray, with the dashed
lines representing a 90% confidence
interval.  (B) Relative size differences 
observed between IM-MS and X-ray
data for monomers (dark colors) and
dimers (light colors) released during
disruption. Dashed lines indicate the




In order to evaluate the agreement between IM-MS derived protein topology 
measurements and those from X-ray datasets, we generated R values from both classes of 
data, which track the relative distance between dimers and monomers within the complex 
(see Supplemental Information).  A plot of IM-MS R values against those extracted from 
X-ray structures reveals a tight correlation between the two for all complexes save two: 
AVD and CAT (Figure 3-2A). For the other six protein tetramers, average topologies, as 
well as much of the total spread of possible topologies created if all charge state-based 
CCS combinations are considered with equal weight, fall within a 90% confidence 
prediction interval. Conversely, the entire range of R values generated from IM-MS for 
AVD and CAT fall outside of the same prediction interval in Figure 3-2A.  Note that 
AVD and CAT present larger R value ranges than the other protein complexes studied 
here, and that such data on its own could be used in broader IM-MS topology 
construction efforts to identify distortion-prone complexes.    
If we evaluate protein CCS measurements used to generate the R values shown in Figure 
3-2A in detail, the origins of the topological defects observed in our CAT and AVD 
datasets becomes apparent (Figure 3-2B).  While CCS values recorded for the intact 
tetramer ions generated under control conditions (200 mM NH4Ac, pH 6.9) are all within 
3% of the expected X-ray CCS values, the disrupted monomer and dimer CCS values 
determined experimentally vary considerably over the eight protein tetramers studied 
here.  Notably, both CAT and AVD display compacted monomer and enlarged dimer 
CCS values. Specifically, AVD disruption generates monomers that are, on average, 
compressed by 3.5% and dimers that possess similarly inflated CCS values when 
compared to X-ray estimates.  CAT dimers are also enlarged by 3.7%, but generate 
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monomer CCS values upon disruption that are 7.5% compressed when compared to X-
ray data. While the data shown in Figure 3-2B provides a clear empirical explanation for 
the topology defects detected in Figure 3-2A, it provides neither a structural explanation 
for the same observations nor a robust analytical methodology to avoid using such IM-
MS data in the construction of CG structures for unknown protein complexes.  
A broader analytical protocol for IM-MS based protein complex topology mapping can 
be derived from the data shown in Figure 3-3, which tracks the IM arrival time profiles 
for all eight protein tetramers under two separate conditions:  those optimized for protein 
disruption and control measurements of ions formed from 200 mM NH4Ac. For six of the 
eight protein complexes, no significant differences are observed between the IM data 
recorded under either conditions (<1% deviation), both in terms of the centriods or peak 
widths of the IM distributions collected (three replicates shown for each dataset).  In two 
cases, however, small yet significant increases (> 1%) are observed in the IM drift time 
centriod observed for intact tetramer ions. Since the intact masses of AVD and CAT are 
identical under both disruption and control solution conditions (Figure S.3-1, 
Supplemental Information), the increase in drift time recorded is likely derived from 
conformational changes in the intact tetramers. These two complexes, AVD and CAT, 
correspond precisely to those that produced erroneous protein CG structures in our 
analysis shown in Figure 3-2.  As such, the observation of similar shifts in IM data for 
intact complexes allows us to detect and remove distorted subcomplex CCS data from 
our modeling constraints.  It is also notable that this strategy can, in theory, be extended 
to protein complexes of unknown structure, as the IM drift time shifts recorded in Figure 
3-3 are not predicated on any knowledge of the tetramer structures studied here. 
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While the criteria we use to construct Figure 3-3 requires similar protein disruption from 
all tetramers studied, significantly different solution conditions are represented in each of 
the lower panels in Figure 3-3 (see Table S.3-1 and Figure S.3-2, Supplemental 
Information), chosen to represent equivalent amounts of protein complex disruption.  
Despite these differences, we note that the six protein complexes that produce high-
fidelity R values when compared to X-ray data do not, under any solution composition 
probed in this chapter, generate ions with shifted drift times.  For example, TTR tetramer 
ions retain their centroid drift time when generated from solutions comprised of 50% 
Figure 3-3 Comparison between the IM distributions and centroids
recorded for intact tetramer ions generated under control (200mM NH4Ac,
upper panel) and disruption conditions (lower panel).  
Three replicates are measured and overlaid for each dataset shown. Blue dashed
lines indicate those datasets where no significant shift in tetramer drift time is
observed (<1%). Red dashed lines indicate those cases where a drift time shift




DMSO and 4M NH4Ac, while CAT displays the shifted drift time profile shown in 
Figure 3-3 at 33% DMSO and 2M NH4Ac.  Previously published results for the CON 
tetramer support these findings, where methanol-based disruption of the tetramer results 
in both dramatically enlarged intact complexes and distorted monomeric subunits upon 
disruption.51  Thus, taken as a complete dataset, the results shown in Figure 3-3 constitute 
a general analytical framework for detecting those conditions likely to produce deformed 
protein subcomplexes through disruption, as the swelling of intact protein complex CCS 
appears to accurately predict the formation of such deformed sub-assemblies.   
A detailed analysis of the X-ray data available for the eight protein tetramers studied here 
provides a structural explanation for the data shown in Figures 3-2 and 3-3.  First, the X-
ray structures for the monomeric units within the CAT and AVD tetramers are the least 
spherical of the complexes studied here (Figure S.3-3A, Supplemental Information).  
Furthermore, AVD and CAT exhibit both the largest number of inter-protein contacts per 
unit mass (Figure S.3-3B, Supplemental Information) and the most closely-packed 
monomers (Figure S.3-3C, Supplemental Information) in our field of tetramers.  In 
summary, therefore, AVD and CAT are comprised of relatively non-spherical subunits, 
possessed of larger than average protein-protein interfaces, and exhibit comparatively 
tight inter-subunit packing. Given such a description, it is relatively facile to rationalize 
the data shown in Figures 3-2 and 3-3. AVD and CAT subunits are likely more stabilized 
by inter-protein contacts than the subunits that make up the other complexes studied here, 
thus making them more-prone to deformation upon release from their respective 
tetramers.    
87 
 
In an effort to find those disruption conditions capable of generating subcomplex CCS 
Figure 3-4 AVD topology models from IM-MS data are brought into close
agreement with X-ray when disruption conditions incorporating high ionic
strength are used.  
(A) 2D titration results for AVD using DMSO and NH4Ac as disrupting agents. (B)
Overlay of two IM-MS contour plots extracted from the dataset shown in (A) (green
and orange). (C) A comparison of the drift time distributions recorded for the
remaining intact tetramer ions formed from the two disruption conditions (lower
panels) with those measured under control conditions (200 mM NH4Ac, upper
panels). (D) The relative errors in monomer size measured by IM when compared to
X-ray data for different AVD monomer charge states derived from the disruption




values for AVD and CAT that are in close agreement with X-ray data, we initiated a 
thorough analysis of all IM-MS data collected in our screens.  An example of such an 
analysis is shown in Figure 3-4, where we use a contour plot to represent the relationship 
between AVD tetramer signal intensity, DMSO solution fraction, and NH4Ac 
concentration (Figure 3-4A).  Within this dataset, each of the 49 data points used for its 
construction represent a complete IM-MS spectrum (Figure 3-4B), and comparison of 
multiple points within this plot reveals stark differences in the dissociation patterns of the 
AVD tetramer. Two drift time versus m/z plots are shown, overlaid, in Figure 3-4B, one 
acquired from a solution containing 53% DMSO with minimal (10 mM) NH4Ac and the 
other containing 33% DMSO and 4 M NH4Ac.  Preparing AVD in higher salt-
concentration solutions prior to nESI engenders lower than average charge states for both 
intact complexes and disruption products as well as an absence of any dimer signal when 
compared to IM-MS data acquired from solutions containing low salt and higher amounts 
of organic co-solvent. Charge states for the AVD tetramer under control conditions range 
from 14+ to 17+, while charge states from 11+ to 15+ are observed under conditions of 
high salt (green data, Figure 3-4B) and 15+ to 20+ when low salt is coupled with large 
amounts of DMSO in solution (orange data, Figure 3-4B).  When the IM drift time 
profiles from charge states that sufficiently overlap with control data are compared, it is 
clear that the AVD tetramer shifts its size when large amounts of DMSO are used for 
protein disruption in the absence of high salt concentrations (Figure 3-4C, orange), as 
observed in Figure 3-3.  However, when a similar comparison is made for disruption 
conditions that add 4M NH4Ac, no shift is detected under conditions that lead to complex 
disruption (Figure 3-4C, green).  Analysis of the monomer CCS values from both of these 
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datasets reveals an agreement with X-ray data to within acceptable errors when disruption 
is performed under conditions of high salt (Figure 3-4D, green), but not when solutions 
with added organic solvent are used (Figure 3-4D, orange).   A few caveats surround the 
result presented in Figure 3-4.   Most notably, the lack of a dimeric subcomplex 
disruption product for the AVD tetramer under the high salt conditions presented means 
that such a result, on its own, does not provide sufficient information to generate the CG 
structure and R values analyzed in Figure 3-2.  In addition, similar conditions that lessen 
the deformation experienced by disrupted monomers have yet to be discovered for the 
CAT tetramer.  Regardless, the results presented in Figures 3-2, 3-3, 3-4, and S.3-3 
provide a general picture that illustrates the overall agreement between IM-MS and X-ray 
datasets, methodologies that enable the detection of distorted subcomplex formation in 
unknowns, and approaches that enable the recovery of partial subcomplex CCS data from 
proteins previously distorted in a more-general screen.   
3.3.2 Solution Disruption followed by IM-MS Reveals the Details of 
Protein-Protein Interface Chemistry 
Figure 3-4A indicates that the AVD tetramer responds more strongly to DMSO as a 
disruption agent than NH4Ac.  For example, by following a vertical line fixed at 10% 
DMSO concentration in Figure 3-4A, it is apparent that no AVD tetramer disruption 
occurs during such an NH4Ac-only titration. This observation could indicate a general 
correlation between the chemical nature of the protein-protein interfaces within the 
complex and the disruption of the intact assembly under specific solvent conditions as 
recorded by IM-MS. In order to pursue this basic premise, we analyzed the 
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multidimensional DMSO/NH4Ac titration data for all eight protein tetramers studied in 
this chapter (Figure 3-5A), and evaluated them for general correlations with X-ray data.   
Each dataset shown is individually normalized to the tetramer intensity observed for a 
given complex under control conditions (200 mM NH4Ac, 0% DMSO), and each contour 
transition shown represents a 10% relative decrease in tetramer signal intensity observed. 
Every protein complex represented in Figure 3-5A displays a unique disruption pattern as 
a function of DMSO and NH4Ac solution content, and qualitative comparisons between 
the plots illustrate how such data can be used to differentiate assemblies based on the 
general strength of their non-covalent protein interactions. For example, TTR, AVD, and 
CAT are amongst the most disruption resistant of the complexes studied here relative to 
DMSO/NH4Ac titration, as evidenced by the relatively large number of total solution 
conditions probed in our screen where IM-MS data records only intact tetramer for these 
three cases.  Of these three, CAT exhibits the steepest descent from 100% intact tetramer 
to complete disruption of any of the complexes studied here, once a sufficient threshold 
amount of disrupting agent is reached.  PKI also represents a unique disruption profile, as 
the tetramer does not generate subcomplex ion current as a function of DMSO added in 
solution unless a certain threshold of NH4Ac is present as well.  Previous studies have 
shown that key salt bridges within the PKI protein-protein interfaces exist and stabilize 
the quaternary structure of the complex.52  Our IM-MS data agrees well with these 




Figure 3-5 Solution disruption followed by IM-MS reveals the details of protein-
protein interface chemistry. 
(A) 2D titration results obtained for the eight homo-tetrameric protein complexes studied 
here, where NH4Ac concentration (M) is plotted against DMSO solution content (%). The 
colors shown indicate the normalized intensity of the tetramer ion signal recorded under 
each solution condition, from red (100%) to blue (0%). Correlations between our IM-MS 
titration experiments (top) and X-ray structure data (bottom) are presented in three 
histogram plots (B), (C) and (D). (B) Normalized intact tetramer intensity integrated over 
all disruption conditions vs. the number of contacts per unit kDa calculated from X-ray 
data. (C) The DMSO % in solution, without added NH4Ac, required to initiate tetramer 
disruption (signal drops by 10%) vs. the estimated average strength of hydrophobic 
contacts within the protein-protein contacts from X-ray (Å-6/MDa). (D) NH4Ac 
concentration required for tetramer disruption at fixed 10% (yellow) and 30% DMSO 
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(blue) vs. the estimated average strength of the polar interactions (Å-1/kDa) within the 
protein-protein contacts from X-ray.  For all datasets, bars marked with a grid pattern 
indicate that the complex did not undergo disruption using any amount of the selected 
agent under the conditions of the screen.  Linear correlation coefficients between IM-MS 
and X-ray datasets are discussed in the text. 
 
In addition to the qualitative analysis above, a quantitative comparison between IM-MS 
and X-ray datasets are necessary to extend the application of the data shown in Figure 3-
5A to unknown protein complexes. We begin by noting the strong correlation between 
the integrated areas found by IM-MS multi-dimensional titration corresponding to those 
conditions where tetramers remain completely un-disrupted (red-shaded areas within 
Figure 3-5A) and the normalized number of inter-protein contacts contained within the 
X-ray structures for the complexes studied here (Figure 3-5B). These two parameters 
appear to be linearly correlated in our dataset, having an R2 value of 0.826, despite the 
fact that our analysis clearly over-simplifies the complex nature of the underlying 
disruption mechanism.  We extended this analysis to include narrower definitions for the 
inter-protein contacts and discovered additional strong correlations between IM-MS and 
X-ray structure data.  By keeping the NH4Ac concentration of protein complex 
containing solutions at fixed minimum values, and titrating DMSO content, we observe a 
strong correlation between the amount of tetramer disruption observed by IM-MS and the 
calculated strength of the inter-chain hydrophobic contacts revealed by X-ray (Figure 3-
5C), generating an R2 value of 0.931 to a linear relationship. We find a somewhat less-
strong linear correlation coefficient of 0.797 between the strength of polar inter-protein 
interactions and tetramer disruption efficiency as a function of NH4Ac concentration in 
solutions with fixed DMSO content (yellow data, Figure 3-5D). The weaker correlation 
we observe for polar interactions in our IM-MS data can be attributed, in part, to the lack 
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of orthogonality between the types of molecular interactions likely disrupted by DMSO 
and NH4Ac. While polar and non-polar interactions can be accessed exclusively by 
DMSO and NH4Ac respectively in our screens,  both solvents likely affect H-bonds 
within protein interfaces.50 In addition, the long-range nature of polar and electrostatic 
interactions, in contrast to the forces involved in non-polar interactions, may elicit non-
native contacts within complexes during disruption, thus degrading the observed 
correlation.53,54 There are a number of caveats associated with these correlations, 
however.  For example, NH4Ac content alone does not dissociate any of the complexes 
studied here; therefore, a baseline level of DMSO is required to generate the correlations 
associated with polar interaction strength.  Specifically, when DMSO content of the 
solutions is locked at 10%, and NH4Ac concentration is ramped, TTR, CAT and AVD do 
not generate any measurable disruption products over the range of salt probed in this 
chapter (10mM to 4M).  Similarly, by increasing the fixed DMSO value to 30%, CON, 
ADH and GL all undergo disruption such that the intact tetramer is 50% depleted.  The 
linear correlation coefficient recorded under this condition is similar to that generated by 
our data when minimal DMSO is used during the titration (blue data, Figure 3-5D, R2 = 
0.775).  Also, PKI is not observed to undergo disruption as a function of DMSO content 
when the NH4Ac concentration is kept at 10mM (the maximum DMSO solution content 
in our screen is 67%).  We attribute this observation to the critical salt-bridges known to 
stabilize the protein-protein contacts in the PKI tetramer, as discussed above. Despite 
these caveats, we find that the correlations between IM-MS titration data and X-ray 
protein-protein contact data are surprisingly strong, and likely pave the way for future use 
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of such quantitative values for different types of inter-chain interactions to constrain 
models of unknown protein complexes.  
3.4 Conclusions 
Here, we utilize robotically-assisted multidimensional titration of disrupting agents in 
solution to probe the ability of IM-MS to produce topology models in agreement with 
existing X-ray data for a series of eight tetrameric proteins.  Our final dataset contains 8 
2D screens of protein complex disruption, using both ionic strength and organic content 
axes, containing ca. 400 individual protein complex IM-MS datasets, each rich with size 
and mass data and many individual signals.  As such, the acquisition of this data was 
greatly enabled by our automated approach.  In addition, the ability to robotically-
manipulate samples with great precision facilitates the cross-dataset comparisons 
discussed throughout this chapter. We demonstrate that R values computed from IM-MS 
data agree well with the majority of those extracted from X-ray.  Clear disagreements are 
found in the case of the AVD and CAT tetramers, and we rationalize these observations 
based on the large number of inter-subunit contacts found within these two complexes 
that likely stabilize their relatively aspherical subunits.  Furthermore, a careful analysis of 
IM-MS data allows deformed protein subcomplexes to be detected, even in the absence 
of X-ray comparisons, as tetramer CCS increases and broadened R value ranges are 
recorded in concert with such subcomplex distortions.  Also, careful analysis of multi-
dimensional titration data enables the collection of IM-MS information under conditions 
that better match X-ray structures, as we demonstrate in the case of the AVD tetramer.  In 
addition to providing foundational data for future protein topology discovery efforts 
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using IM-MS, the data presented here provides evidence of solution phase memory 
effects for proteins and their associated complexes, adding substantially to previous 
reports.22,51,55-57 The data shown here is the first to indicate that there are broad sets of 
solution conditions that are cable of reorganizing protein structure in such a way to 
influence the resulting gas-phase conformation of intact protein ions, and it is clear that in 
future IM-MS efforts to constrain protein topology models data similar to those shown in 
Figures 3-3 and 3-4 should be acquired to direct and evaluate the use of subcomplex size 
information in protein complex model generation. 
Our IM-MS titration data are also used to generate quantitative values associated with the 
number and type of stabilizing interactions that populate protein-protein interfaces.  By 
determining the ratios of intact tetramers to disrupted subcomplexes over a controlled 
range of solution conditions, we find strong correlations between IM-MS and X-ray 
datasets.  We estimate the average relative errors for this type of measurement at +/- 27% 
for quantifying polar interactions, 14% for hydrophobic interactions, and 33% for total 
numbers of interactions per-unit mass (see Supplemental Information for the details of 
this error calculation).  Such data is potentially highly-complimentary to CXL12 and 
HDX13 MS information.  While providing a lower-resolution estimate of protein-protein 
interface area than these other MS approaches, such IM-MS based multi-dimensional 
titration results may provide quantitative values for different types of inter-chain contacts 
within protein assemblies that are not accessible to protease digestion or present at low 
levels, following appropriate calibration with proteins of known structure. 
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3.5 Supplemental Information 
X-ray and IM-MS Structure analysis.  To quantitatively evaluate the agreement 
between X-ray and IM-MS structure information, we computed a number of values 






        (S.3.1) 
 
which is a ratio of the distance between the geometric centers of the two dimeric 
subcomplexes that comprise the tetramer over the distance between the two monomeric 
units that comprise those dimers.  We also computed the relative size differences between 
crystolographic and IM-measured monomers: 
%	Monomer	Size	Difference              (S.3.2) 
where the monomer size from both datasets is expressed as a fraction of the total complex 
size.  A similar metric is also used in our data to evaluate dimer size agreement between 
X-ray and IM datasets: 
%	Dimer	Size	Difference 																																																																				               
(S.3.3)   
For X-ray data analysis alone, we have developed several useful metrics that we use to 
evaluate the trends observed in our IM-MS dataset.  First, we calculate the asphericity of 
protein subunits in complexes using Equation S.3.4:  
Monomer	Asphericity	Index     (S.3.4) 
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where LAV is the average distance between the protein center-of-mass and its surface, and 
LSD is the standard deviation of all of the length measurements used to define LAV.  
Larger index values indicate less-spherical monomers. The second method of X-ray 
structure analysis used here involves counting the number of inter-chain contacts within 
protein complexes.  These values are normalized by the total molecular weight of the 
proteins studied here to generate a contact-per-unit mass (kDa) value for each tetramer 
included in this chapter. Cut-off distances for inter-protein contacts were defined as 4 Å 
for both salt bridges (Lys/Arg/N-terminus with ASP/GLU/C-terminus) and hydrophobic 
(C-C) interactions and 3.5 Å for hydrogen bonds (polar-polar or charged-polar residue 
interactions). Total contact number values sum the contacts discovered in all three 
categories.  Where interaction strengths are indicated, these values are computed using 
either:  
           (S.3.5) 
where d is the distance between contacting residues for both salt bridge and h-bonds in 
the context of polar-type interactions (equation derived from calculations used to estimate 
the strength of electrostatic interactions58) or: 
      (S.3.6) 
for apolar interaction strength values, where d is the distance between hydrophobic 
interacting amino acid residues (equation derived calculations used to estimate the 
strength of van der Waals interactions1).  The final X-ray structure analysis method used 




              (S.3.7) 
where the larger the monomer proximity index value, the closer the packing of 




PDB IDs for complexes studied here are: 1ICT for TTR, 3VHM for AVD, 1VAL for 







Figure S. 3-1 A comparison between the m/z and intact mass recorded for tetramer 
ions generated under control (200mM NH4Ac, upper panel) and optimized 
disruption conditions (lower panel) discussed in Figure 3-3.  
Three replicates are measured and overlaid for each dataset shown. Minimum smoothing 
is used for the data shown. The charge states displayed are the 16+ for AVD and the 28+ 
for CAT. The actual mass shifts observed for these assemblies under conditions 
optimized for protein complex disruption were +8.7 Da for AVD and -31.9 Da for CAT, 





Table S. 3-1 Solution conditions optimized for protein complex disruption, used in 
Figure 3-3. 
 
Protein complex Solution Conditions Optimized for Protein Disruption 
TTR 47% DMSO, 4M NH4Ac 
AVD 53% DMSO, 10mM NH4Ac 
CON 17% DMSO, 3M NH4Ac 
ADH 17% DMSO, 2M NH4Ac 
ALD 33% DMSO, 1M NH4Ac 
PKI 17% DMSO, 2M NH4Ac 
CAT 33% DMSO, 2M NH4Ac 
















Figure S. 3-2 The positions of the disruption conditions shown in Table S.3-1 within
the 2D titration maps shown in Figure 3-5A.   
Conditions were selected based on two criteria: 1) That they contain optimized signal for
both dimer and monomer ions and 2) that at least 50% of the intact tetramer had
undergone dissociation. Conditions optimized for AVD disruption, as shown in Table
S.3-1 and discussed as the ‘orange dataset’ in Figure 3-4, were chosen to maximize dimer
signal intensity, even though intact tetramer disruption is not as complete as in the other























Figure S. 3-3 Comparing X-ray and IM-MS data provides
critical insight into the structural deformations observed in
AVD and CAT subcomplexes.  
(A) Asphericity index values calculated for subunits within each
protein complex. Larger values indicate a less globular shape for
protein subunits. (B) The average number of contacts per-unit kDa
within the protein-protein interfaces of the complexes studied in
this chapter. (C) A monomer proximity index, calculated using the
square root of the dimer size divided by the linear distance
between the monomers that form the biological dimer for each
complex. The larger the index value, the more-tightly packed the
monomers within the X-ray structure. For all panels, the solid lines
shown indicate average values for each metric, while dashed lines
indicate ± one standard deviation from the mean.  Each value




Figure S. 3-4 Correlations between IM-MS disruption experiments using a three-
component titration strategy and salt bridge strength calculations from X-ray
structure data   
(A) A histogram plot showing the calculated strength of the salt-bridge interactions found
in the smaller ‘loose’ interfaces within the X-ray structures of the complexes studied
here, over those found in the larger ‘tight’ interfaces.  The solid line shown indicates the
mean value for this ratio for all eight tetrameric proteins studied, while dashed line
indicates + one standard deviation from the mean. An analysis of this ratio suggests that
significant salt-bridge based interface strength asymmetry exists in the AVD and CAT 
tetramers, but not in the other complexes studied here.   (B) Monomer and dimer intensity
values recorded during the three-component disruption of the AVD tetramer, utilizing
NH4Ac, DMSO and acetonitirle (ACN).  Organic content in this plot is fixed at 33%
DMSO and 33% ACN. (C) Monomer and dimer intensity values for the CAT tetramer
using a similar screen as in B.  Methanol replaces ACN, but total organic content is fixed
33% DMSO and 33% methanol.  In both B and C, clear divergent trends are observed
between monomer and dimer signal intensity, favoring dimer formation only at the low




Figure S. 3-5 Correlations between our IM-MS titration experiments (X axis) and 
X-ray structure data (Y axis), shown as a scatter plot with fitted trend lines. Dashed 
lines indicate the 95% confidence interval for each fit.  
(A) Normalized intact tetramer intensity integrated over all disruption conditions vs. the 
number of contacts per unit kDa calculated from X-ray data. (B) The DMSO % in 
solution, without added NH4Ac, required to initiate tetramer disruption (signal drops by 
10%) vs. the estimated average strength of hydrophobic contacts within the protein-
protein contacts from X-ray (Å-6/MDa). Red data point represents PKI, which is excluded 
from the fit. (C) NH4Ac concentration required for tetramer disruption at fixed 10% and 
30% DMSO (D) vs. the estimated average strength of the polar interactions (Å-1/kDa) 
within the protein-protein contacts from X-ray. The correlation equations and linear 
correlation coefficients between IM-MS and X-ray datasets are each shown in the 
corresponding panel. The error estimates in the text indicates the difference between 
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Chapter 4. The Collisional and Coulombic 
Unfolding of Gas-Phase Proteins is Highly-
Correlated to Their Domain Structure in 
Solution 
4.1 Introduction 
Rapidly characterizing the three-dimensional structures of  proteins, and their higher-
order complexes, is an unquestionably-important goal in the  post-genomic era.1  Large-
scale protein structure determination efforts have enabled countless discovories in 
biochemistry and medicine and, as the component list of the cellular proteome takes 
shape and definition, the significance of such work has become increasingly evident.2  In 
addition, similar endeavors have served to support protein engineering projects that seek 
to develop optimized enzymes for specific chemical transformations.3 Both the growing 
need to structurally characterize small molecule pharmaceuticals bound to their protein 
targets, as well as the influence of analagous data during the development of 
biotherapeutics, underscores the impact of protein structure analysis in the context of  
pharmaceutical discovery and development.4 
While X-ray and NMR analyses provide invaluable high-resolution protein structure 
information, mass spectrometry (MS) technologies can be engaged to provide protein 
structural constraints in a manner orthogonal to these more-established techniques.5 The 
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growing suite of MS technologies enables measurements on a range of structural levels, 
and includes: chemical cross-linking,6-8 H/D exchange,9-14 oxidative footprinting,15-17 ion 
mobility (IM) separation,18-23 and MS of intact complexes.24-26  Many examples exist 
where MS datasets have provided structural details for protein targets where few existed 
previously by offering significant advantages in in terms of speed, sample consumption, 
and complex mixture analysis.27,28   Many of the contributions of MS-based structural 
analysis have been related to protein quaternary structure, including models of the 
eukaryotic exosome,29 ribosomal initiation factor,30,31 signalosome,32 replisome,33,34 
chaperone,35-39 ATPase,40 and transcriptional regulation complexes.41  
Despite successes in defining the overall architecture of multiprotein machines, MS 
technologies have fewer approaches available to determine the more-local elements of 
structure within these assemblies.  Intra-molecular cross-linking can be used in small 
systems to constrain protein folding models, but such approaches currently have 
significant size limitations.8 H/D exchange and oxidative footprinting data can be 
interpreted in the context of pre-existing high-resolution structures, but using such data to 
define unknown structures at a local level is currently a daunting task.42 IM 
measurements have been used in conjunction with molecular dynamics for well over a 
decade to generate high-fidelity structures for peptides and small proteins,43-45 but the 
size information contained within the IM measurement often loses its ability to 
adequately filter models for larger protein systems. As such, there is a clear need to 
develop MS-based technologies capable of providing local structure information within 
larger protein monomers. 
111 
 
Gas-phase measurements of global protein structure are now over two decades old,46 and 
have revealed that small, single domain protein ions adopt both compact and unfolded 
conformations in the absence of bulk solvent. These transitions were first recorded in a 
manner correlated with protein charge state, which is in turn correlated with protein 
surface area in solution.47-51  The resulting ions adopt conformers that are compact for 
low charge states but grow increasingly extended as their overall charge is increased. 
These experiments revealed a range of Coulombically-unfolded protein conformational 
families, and have recently led to more extensive studies. For example, IM measurements 
of ubiquitin ions created from acidified, methanol-containing samples are consistent with 
the known ‘A state’ of the protein, a less compact and partially folded form of the 
biopolymer observed under such conditions in solution.52-54 Further, IM measurements 
have identified two distinct families of structures for the intrinsically disordered protein 
α-Synuclein, a key biomolecule implicated in the etiology of Parkinson’s disease.55  In 
addition to Coulombic unfolding, compact protein ions can be activated in the gas-phase 
to produce a range of unfolded conformations.  As above, the activation-initiated 
unfolding of protein ions in the gas phase was first observed in small monomeric systems 
through collisional48,51 and thermal56 means of excitation. Subsequent IM and IM/IM 
experiments have illustrated the kinetic and energetic stability of protein ion conformers 
over timescales ranging from seconds to microseconds.57-59   
Measurements of gas-phase structure have been applied more-recently to intact 
multiprotein complexes, and have revealed much regarding the structural transitions that 
occur for these multi-chain protein systems following activation in the absence of bulk 
solvent. Building upon pioneering work that provided the first entropy estimates for the 
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transition states associated with protein complex dissociation,60 and chemical cross-
linking experiments that directly related the charge asymmetry found in product ions 
produced by collision induced dissociation (CID) to protein unfolding,61 discrete 
unfolded forms of multiprotein complex ions were captured using IM-MS measurements 
following collisional activation.57,62  Our current pool of evidence points to a collisional 
unfolding mechanism for multi-chain protein complexes that leads to asymmetric 
structures where a single chain unfolds to a much greater extent than all others within the 
complex.  This asymmetric unfolding of a single chain amongst many is most-likely 
driven by mobile protons on the surface of the protein,63 that migrate towards thermally-
unfolded regions within the structure.61-64 As dictated by this mechanism, the general 
asymmetry of the unfolded multi-chain structure produced following collisional 
activation depends strongly upon the charge state of the ion selected,65,66 and  the time-
scale over which ion activation occurs.67 
In most of the work discussed above, gas-phase unfolding is employed as a means to 
study the role of solvent in determining the final native structures adopted by the protein.  
Recent trends, however, have pointed to the analytical utility of such unfolding data, 
specifically in its ability to detect subtle shifts in protein structure and stability in a 
manner correlated with known conformers in solution. Specifically, collision induced 
unfolding (CIU) data for protein-protein36,68-70 and protein-ligand35,71-73 complexes have 
demonstrated an ability to discover critical stability differences and distinguish solution-
phase ligand binding modes by tracking the size of the unfolding protein as a function of 
the amount of activation energy provided during the experiment.  These results are 
particularly significant given the above discussion, as they link IM-MS data to local 
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structural elements within large proteins, although thus far such links have largely been 
generated through a fingerprint-type analysis of the unfolding data collected.71  
Here, we report on the first use of gas-phase unfolding as a means to determine the 
number of autonomously-folded domains within monomeric proteins. By selecting a 
broad range of proteins, containing both different numbers of autonomous domains and a 
range of local folds, we are able to identify persistent trends in gas-phase unfolding that 
will likely hold for proteins in general. Collisional and Coulombic unfolding data both 
provide clear, unmistakable correlations to the known domain structure of the 18 proteins 
and protein isoforms chosen for our study, ranging from 8 to 78 kDa in intact molecular 
mass. We include detailed criteria for selecting charge states for CIU analysis, and for 
defining signal-to-noise levels useful in detecting domains within Coulombic unfolding 
datasets. We conclude by discussing the implications for the correlations identified 
herein, both for multi-protein structure determination efforts by MS and for rapid 
biotherapeutics characterization in the future. 
4.2 Experimental 
4.2.1 Sample Preparation 
Proteins were acquired from the following sources: ubiquitin (bovine, Sigma U6253), 
linear di-ubiquitin (human, BostonBiochem UC-700-100), linear tri-ubiquitin (human, 
Enzo life sciences BML-UW0780-0100), linear tetra-ubiquitin (human, Enzo life 
sciences BML-UW0785-0100), cytochrome C (horse, Sigma C2506), glutathione S-
transferase (schistosoma japonicum, provided by the Ragsdale lab at the University of 
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Michigan, purified and prepared using a previously-published procedure74), serum 
albumin (bovine, Sigma A7906), green fluorescent protein (GFP, Aequorea Victoria, 
Prospec PRO-687), -D crystallin (human, Creative Biomart CRYGD-3634H) and 
fibronectin III 8-10 N-GST (human, Kerafast EUR116, the GST tag was removed by 
treatment with a Thrombin CleanCleave Kit from Sigma and purified using a glutathione 
sepharose 4B column from GE Healthcare). Standards for collision cross-section (CCS) 
calibration include: a commercially-available peptide mixture (Waters 186002337), 
cytochrome C, and the protein complexes avidin (Sigma A9275), concanavalin A (Sigma 
C2010), alcohol dehydrogenase (Sigma A7011), and glutamate dehydrogenase (Sigma, 
G7882). The peptide mixture (~2 µM for each peptide) was prepared in a 
water/methanol/ acetic acid (49/49/2) solution. All other proteins were solubilized in 200 
mM aqueous ammonium acetate (NH4Ac) solutions, or kept in their original solution 
conditions, and flash frozen for storage at -80 . In general, stock samples (≥30 µM), 
were buffer-exchanged into a 200mM NH4Ac solution (described above) prior to IM-MS 
analysis, using a Micro Bio-Spin 6/30 column (Bio-Rad, Hercules, CA). For CIU 
experiments, all monomeric proteins were diluted into 200 mM NH4Ac to a final 
concentration of 5-10 µM before analysis, except glutathione S-transferase, which 
required treatment with 40% dimethyl sulfoxide and 1 M NH4Ac to convert the native 
dimer into its folded monomeric form. For Coulombic unfolding, proteins were denatured 
in solution using a combination of methanol, acetic acid and, in some cases, dimethyl 
sulfoxide, optimized for each protein to achieve a maximum range of charge states. 




4.2.2 IM-MS Instrument and Methods 
IM-MS data were acquired on a Synapt G2 (Waters, Milford, MA) optimized for the 
transmission of intact protein and protein complexes as described previously,21 using 
nano-electrospray ionization (nESI). For CIU experiments, individual protein charge 
states were first selected by tandem MS using a quadrupole mass filter. The selected ions 
were then activated in the ion trap region of the instrument using energetic collisions with 
Ar (3×10-2 mbar) prior to IM separation.  IM separates proteins according to their 
orientationally -averaged collision cross section (CCS) by driving ions through a gas-
filled chamber with an applied electric field.21-23,75-78 Ramping the bias voltage value that 
dictates the static voltage offset between the exit of the quadrupole filter and the inlet of 
the ion trap (termed ‘trap CE’ in the instrument control software) allowed for the 
collection of CIU related unfolding in an energy-resolved manner, revealing gas-phase 
protein conformations stable on the millisecond timescale, as observed previously.35,36,68-
71,73 In each CIU experiment, collision voltage was ramped in 2V increments until protein 
backbone fragments were observed. Coulombic unfolding datasets are presented without 
m/z filtration or any gas phase activation. IM resolution was optimized for all datasets 
collected by operating the T-wave separator under conditions of high N2 pressure (3-4 
mbar), high wave height (40 V) and medium wave velocity (400-900 m/s).79  
4.2.3 Data Analysis 
Initial IM-MS Data processing was performed using Masslynx v4.1and Driftscope v2.0 
(both from Waters, Milford, MA). IM calibration to a He CCS axis was performed based 
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on a previously-described method, producing highly-linear calibration plots (R2 > 0.96). 
CIU contour plots charting protein CCS versus collision voltage were generated by 
Origin software package. The color scale in these plots indicates the signal intensity 
recorded for each conformer family at the indicated collision energy values, normalized 
to the highest signal of each collision voltage. Solvent accessible surface areas for all 
proteins were calculated with GETAREA (www.curie.utmb.edu/getarea.html ) using the 
appropriate Protein Data Bank entries (PDB codes are listed in supplemental 
information).  
4.3 Results and Discussion 
Protein coordinate files deposited in the PDB are classified in both the SCOP (Structural 
Classification of Proteins)80 and CATH (Class, Architecture, Topology and Homologous 
superfamily protein structure classification)81 databases according to their domain 
structures (Table S.4-1). While both databases  assign  proteins  according to their 
structures, they do so using different criteria, formalisms, and differing amounts of 
experimental data.82-84 For our experiments, we drew from both of these existing 
databases to assemble a series test proteins covering a broad range of domain structures 
and local folds in order to test the breadth of the correlations we discovered between 








A native two-domain protein
(A) is subjected to collisional
unfolding in the gas-phase
(B) or Coulombic unfolding
through denaturation in
solution (F). (C) An example
overlay of collisional
unfolding data collected over
a range of collision voltages,
resulting in three
conformational families I
(blue), II (red) and III (green)
observed at low, medium and
high voltage values
respectively. (D) The drift
time profile is converted into
cross-sectional data for each
collision voltage. (E)
Combined data recorded
under all collision voltages,
where collision cross-section
(CCS) is plotted against
collision voltage. Colors
denote signal intensity as
indicated. (G) Drift time
profile of Coulombically
unfolded protein ions. In
addition to the three general
regions of protein unfolding
shown I (blue), II’ (red) and
III’ (green), 2 intermediate
stages, marked A and B, are
also observed. (H) Calibrated
data plotting CCS against
protein charge state. (I) A
first derivative plot where
CCS is plotted as a function
of charge state, serving to
highlight stages A and B. 
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Figure 4-1 illustrates our general experimental protocol. For example, a monomeric 
protein with 2 distinct domains (4-1A) can be sampled using nESI in two separate 
analysis streams. In the first experimental track, protein ions created under native 
conditions are selected for collisional activation (4-1B). Energy-resolved IM-MS data, 
acquired over a range of bias voltage values between the exit of the quadrupole mass 
filter and the ion trap region prior to IM separation, is used to track the unfolding of 
individual charge states of the protein monomer ion population (4-1C). IM Drift time data 
is converted to CCS in order to directly correlate the unfolding data to protein sizes and 
enable comparisons between different proteins and replicate runs on the same protein 
system (4-1D). These CCS data are then combined into a CIU fingerprint, where the 
energy required to unfold the protein ions can be readily identified for each conformer 
family detected (4-1E). Our CIU data analysis involves assessment of the total number of 
resolved features observed in drift time/CCS space in excess of the initial population 
detected, and correlates this number with the number of known domains within a given 
monomer.   
The second experimental track involves proteins paritally denatured in solution using a 
combination of organic and acidified solvents prior to nESI (4-1F). These data are 
characterized by the extensive charging of the protein ions produced, in a manner 
correlated with their increased surface area upon unfolding, and the drift time profiles for 
such ions are recorded for all of the charge states generated (4-1G). As observed 
previously, protein ions adopt a broad range of unfolded or partially unfolded structures 
upon charging (Figure S.4-1). The degree of unfolding observed for monomeric protein 
systems can be divided into three main categories as a function of the charge adopted by 
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the protein. At low charge states, minimal or no unfolding is observed. Intermediate 
unfolding is observed as charge is increased; typically accompanied by multiple co-
populated protein conformer families and by broadened or multi-modal IM drift time 
profiles.  Ultimately, highly-charged proteins achieve string-like conformations in the 
absence of solvent. Our analysis tracks all of this data in both IM drift time and CCS 
space (4-1H), and uses a simple derivative analysis to identify regions within IM data that 
exhibit the greatest change in CCS (CCS, 4-1I), which typically overlaps with charge 
states where the protein ion exists simultaneously in multiple conformations in the gas 
phase.  As above, this enables us to correlate regions of greatest CCS directly to the 
number of domains within the protein being analyzed.  
4.3.1 Estabilising a General Correlation between Gas-Phase Unfolding 
and Protein Domain Number 
We first examine the unfolding properties of ubiquitin, and various covalently-ligated 
analogs, in the gas-phase. Monomeric ubiquitin is currently among the most-studied gas-
phase proteins.54,85-92  IM-MS53,54,92 and tandem IM87 analysis have both been used to 
evaluate the influence of charge and energy on this protein system in detail. Recent 
studies have demonstrated a clear correlation between the folded state of the biopolymer 
in solution and its resultant gas-phase conformer populations.54 The native ubiquitin fold 
is a mixture of  -helix and -sheet secondary structure, making it an ideal initial target 
for our approach. A single ubiquitin domain exhibits two conformational states when low 
charge state protein ions are selected for CIU, and a single CCS feature in our 
Coulombic unfolding dataset, both indicative of a single domain structure (Figure 4-2). 
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As additional ubiquitin domains are added to the C-terminus of the original protein, 
further CIU and Coulombic unfolding signals are observed, each in precise agreement 
with the expected response for the known domain structure of the proteins analyzed 
 
Our CIU data on poly-ubiquitin protein constructs reveal some general trends in the 
domain-related unfolding of gas-phase proteins.  For example, while mono- (5+) and di- 
(7+) ubiquitin CIU fingerprints contain clear, step-wise transitions between the different 
unfolded forms observed, tri- (9+) and tetra- (11+) ubiquitin CIU data reveal more-
complex transitions between intermediate states.  Specifically, conformational families II 
in both the tri- and tetra-ubiquitin datasets shown in Figure 4-2 appear broadened on the 
Figure 4-2 Collisional unfolding (top) and Coulombic unfolding (bottom) data of
poly-ubiquitin domains linked in a linear fashion.  
Charge states used in collisional unfolding experiments are noted on the top left corner.
Conformational families detected are noted with numerals I through V. Intermediate
unfolding stages identified within Coulombic unfolding experiments are labeled A to D.
The dashed line represents an empirically-derived signal cut-off value at CCS =1.5 nm2.
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CCS axis, and possesses a diagonalized shape in CCS/energy space.   While high-
resolution data is not available for the linear tri- and tetra-ubiquitin constructs studied 
here,93,94 and computational tools capable of accurately assessing the structure of the 
unfolding intermediates probed here are also not yet available, it is likely that these 
broadened CIU features relate to the more-complex tertiary arrangement of domains in 
higher-order ubiquitin structures.  Despite these complexities, CCS features are resolved 
in our dataset and the number of these features is clearly correlated with the number of 
autonomously folded domains within the protein. 
Ubiquitin Coulombic unfolding data also reveal trends that can be applied generally to 
multi-domain proteins studied here by IM-MS.  Mono-ubiquitin exhibits maximum CCS 
values at ~7 charges, which compares well to previously-reported IM-MS data for this 
protein.53  In comparison, di-ubiquitin exhibits maximum CCS at ~10 charges, and this 
value increases to ~13 and ~15 charges for tri- and tetra-ubiquitin respectively.  This 
increase correlates closely with the average CCS values for the intact proteins in low 
charge states and estimates of the same based on a fixed-density approach (linear R2 > 
0.99),21 suggesting that initial domain unfolding is strongly correlated with protein ion 
surface charge.    Furthermore, while di- and tri- ubiquitin require relatively equal 
amounts of charge to unfold subsequent domains (4 or 5 charges on average), the 
Coulombic unfolding of tetra-ubiquitin appears less-evenly spaced as a function of 
charge, requiring between 3 and 9 charges to initiate unfolding of subsequent domains.  
As above, this more-complicated relationship between charge state and unfolding is 
likely related to the tertiary arrangement of the domains present in tetra-ubiquitin. 
Importantly, the additional complexity observed does not prevent us from accurately 
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recording the number of domains within this protein using Coulombic unfolding 
measurements.   We have assigned an empirical noise value 1.5 nm2 to all such datasets 
and, when signals observed above this threshold are collected and counted, a clear, 
general correlation between unfolding data and known domain structure is observed.   
4.3.2 Broadening the Unfolding Dataset using Proteins that are 
Predominantly -helical or -sheet  
In order to expand our protein unfolding dataset and evaluate the generality of the 
correlations observed in Figure 4-2, we applied our IM-MS approach to additional 
monomeric proteins that A) exhibit a similar number of total domains as the poly-
ubiquitin system and B) contain individual domains with significantly different fold 
types.  Data shown in Figure 4-3 is derived from a set of proteins that are constructed 
from domains which each contain at least 40% -helix and less than 10% -sheet. In the 
case of cytochrome C, as a single domain protein, we observe two conformational 
families during CIU and one CCS peak from Coulombic unfolding analysis, in a manner 
similar to ubiquitin. For glutathione S-transferase, a two-domain monomer in this 
category, three conformational families and two CCS peaks are measured during CIU 
and Coulombic unfolding experiments respectively. We observe the three-domain protein 
serum albumin to generate four CIU conformational families and three CCS peaks upon 
Coulombic unfolding. All of these results conform precisely to the expected number of 
domains within these proteins, and trends similar to those observed in our poly-ubiquitin 
analysis are also evident in these data.  For example, in a similar fashion to tri- and tetra-
ubiquitin, features I and II in serum albumin appear broadened in CCS space. Also, 
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Coulombic unfolding patterns for serum albumin appear irregularly spaced as a function 
of charge, when compared to the lower-order domain proteins studied here, in a manner 
similar to our findings for tetra-ubiquitin.  Again, since this is only observed in our data 
for higher-order domain structures, we attribute this observation to the tertiary 
arrangement of protein domains within serum albumin, as compared to the more discrete 
domain structures observed in the high-resolution data for cytochrome c and glutathione 
S-transferase.  
Figure 4-3 X-ray structure (top), collisional unfolding (middle) and Coulombic
unfolding (bottom) data for predominantly -helical proteins. 
Including cytochrome C (one domain), glutathione S-transferase (two domains) and
serum albumin (three domains). PDB codes for each X-ray dataset is provided in the
figure, and is color coded according to domain structure.
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While the data shown in Figure 4-3 pertains to primarily -helix proteins, Figure 4-4 
contains data from proteins comprised of domains having more than 40% -sheet and 
less than 10% -helix. We collected CIU and Coulombic unfolding data for GFP, -D 
crystallin and fibronectin, as examples of one, two and three-domain proteins 
respectively within this protein class.  Each protein displays unfolding patterns that 
correspond precisely to their expected number of domains in solution. In addition, the 
trends indicated above for poly-ubiquitin and -helical proteins in Figures 4-2 and 4-3 
hold for the -sheet rich systems shown in Figure 4-4.  GFP represents a somewhat 
unique dataset among those presented here.  The data shown in Figure 4-4 for this protein 
indicates a more-frustrated transition between compact and unfolded forms in both CIU 
and Coulombic unfolding measurement.  Specifically, CIU data show a low intensity 
feature that appears at 21.5 nm2 and an acceleration potential of 45V.  While this feature 
is of very low intensity (maximum relative intensity of <10%) and can be easily ignored 
in the context of our analytical protocol for domain number determination, it does 
indicate a more-complex gas-phase unfolding transition than observed in other single-
domain proteins studied here.  Similar trends are detected in our GFP Coulombic 
unfolding data when the width and asymmetry of the CCS peak detected is compared 
with other single domain protein data shown in Figures 4-2 and 4-3, and may reflect the 
stability and unique architecture of the -barrel domain within our broader database of 
proteins.  However, as in the case of the CIU data shown in Figure 4-4, these 
complexities do not hamper our ability to correctly assign the number of domains within 




Figure 4-4 X-ray structure (top), collisional unfolding (middle) and Coulombic
unfolding (bottom) data predominantly -sheet proteins. 
Including green fluorescence protein (one domain), -D crystallin (two domains) and
fibronectin (three domains). PDB codes for each X-ray dataset is provided in the figure,
and is color coded according to domain structure. 
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4.3.3 Selecting Optimal Charge States for CIU Protein Domain 
Analysis 
One key element to successfully mapping CIU data onto protein domain structure 
involves the initial charge state selection. Higher protein charge states, if selected, 
typically generate a larger number of unfolded transitions that may, or may not, correlate 
with protein domain structure in a manner dependent upon the overall mass and size of 
the protein analyzed. As shown on Figure 4-5, all of the charge states identified in this 
study that produce CIU data in optimal agreement with domain-resolved unfolding 
patters follow a power-law correlation as a function of protein mass (Figure 4-5A) and 
solvent accessible surface area (Figure 4-5B).  Both experimentally observed trends 
reported here are mirrored by previously-observed functions that are used to predict 
average charging of protein ions from native solution in ESI, but are offset to lower 
charge values.95 For protein mass-dependent trends (Figure 4-5A), optimal charge states 
are generally 33% lower than those expected for native proteins analyzed by ESI.95,96 
However, if the solvent accessible surface area is used instead to evaluate this correlation, 
optimal charge states for CIU domain analysis are approximately 15% lower than the 
average expected value for proteins electrosprayed from native solutions.97 Given the 
data presented here, the correlations shown in Figure 4-5 should provide adequate 
information to construct protocols that enable the CIU-based domain analysis of proteins 





In this chapter we have used a group of eighteen proteins to identify and validate a 
fundamental correlation between gas-phase protein unfolding and protein domain 
Figure 4-5 Optimal charge
states for CIU protein domain
analysis  
(A) Protein charge states used
in CIU experiments plotted
against protein mass for thirteen
of the systems studied here (--
●--). R2 for the fit shown is
0.99.  The solid line indicates
expected average charge state
from previous experiments that
use fixed protein density to
estimate surface charging for
protein ions produced from ESI
under native conditions.95 (B)
Protein charge states used in
CIU experiments plotted
against solvent accessible
surface area for the same
systems analyzed in A (--●--),
as determined from available
X-ray structures.97,110 R2 for the
fit shown is 0.96. The solid line
indicates expected average
charge states for these protein
ion surface areas, generated
from ESI under native
conditions, derived from
previous experimental data. 97 
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structure in solution.  Using our IM-MS approach, the number of domains within proteins 
can be identified by recording either the intermediate sizes adopted by in CIU data or by 
measuring the number of regions within Coulombic unfolding datasets that exhibit a large 
rate of change.  These trends are shown to be independent of protein size (8-78 kDa) and 
fold (-helix, -sheet, and mixed protein folds tested).  By selecting charge states that are 
significantly lower than the average produced by ESI from native solutions, CIU data can 
be generated that is highly protein domain-correlated.  For higher-order domain proteins, 
we detect slight aberrations in our data that we attribute to tertiary contacts between 
domains,98 although we cannot rule out the influence of excess Coulombic or thermal 
activation in these higher charge state systems, as observed in previous work.61 Future 
work in our lab will aim to expand our approach to identify ways to mine this data for 
more detailed, structurally-important information. 
The unfolding observed here demonstrates discrete unfolding stages for each domain, 
similar to Atomic Force Microscopy (AFM) experiments where proteins tethered to a 
surface are mechanically unfolded.99-101 Unlike traditional thermal unfolding or solution-
phase unfolding using either guanadinium chloride or urea, in which the homologous 
domains unfold cooperatively,102,103 gas-phase unfolding is likely able to make use of 
subtle structural differences in equivalent domains to initiate the unfolding in only one 
region of the structure. Once triggered, asymmetric protein unfolding is undoubtedly 
driven by a mechanism similar to that previously-described for multi-chain non-covalent 
protein complex ions.104 
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We have also included, primarily in Supplemental Information, a group of examples 
where the proteins are not linked as a single chain but instead connected elsewhere in the 
sequence of the previous domain.  Unsurprisingly, CIU data for such proteins are often 
more complex than the simple correlations shown in Figures 4-2 to 4-4 (K48 and K63 
linked di-ubiquitin, Figure S.4-2),  but since non-linear protein sequences comprise less 
than 3% of the proteome,105 and are easily detected by MS,106 spurious CIU domain 
assignments in unknowns that possess non-linear sequences are unlikely.   Furthermore, 
our data for cytochrome P450 reductase (CPR), a three-domain protein, produces CIU 
data in excellent agreement with known domain number, but produces Coulombic 
unfolding data that is more difficult to interpret, likely due to an inability to identify 
optimized solution conditions for protein denaturation (Figure S.4-3).  Likewise, in the 
case of the Abelson protein tyrosine kinase (Abl) and transferrin, SCOP and CATH 
provide different assessments of the total number of autonomous domains contained 
within the proteins. In the former case, CIU and Coulombic unfolding identify a two 
domain structure in agreement with CATH. In the latter case, Coulombic data is in 
agreement with the SCOP classification, and the CIU with CATH, for reasons that are 
currently unclear (Figure S.4-4).  Due to essential  differences  in methodology, SCOP 
and CATH domain assignments share classifications in 70% of all databse entries.84  
However, domain assignments that agree with either database are expected to be useful 
for structural assignments in unknown systems, and our current database of IM-MS data 
for linear biopolymers provides clear agreements with either one or both databases in all 
cases.   Finally, in the case of billverdin reductase (BVR) (Figure S.4-5), a two domain 
structure where each domain is spatially-intermingled with the other, the Coulombic 
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unfolding data is in strong agreement with CATH domain analysis, but CIU produces 
data that suggests a weak third domain within the system, perhaps due to the 'swapped' 
nature of the domain structure in the protein.107,108 As in the case of non-linear protein 
sequences discussed above, 'swapped' domain architectures are expected to account for 
an exceedingly small portion of the proteome (less than 0.3% of all complexes), thus 
minimally impacting the ability of IM-MS to assess the domain structure of unknown 
proteins.109 As such, a clear relationship is identified between gas-phase unfolding and 
known domain architecture, and in future studies, these unfolding data may be used in 
combination with other biophysical probes to more-completely annotate the 
autonomously folded regions within currently unknown protein systems.   
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4.5 Supplemental Information 
Table S. 4-1 Detailed information for proteins used in this chapter, including 
protein names, organisms, masses, PDB codes, secondary structure content (helix 
and sheet percentage) and domain numbers defined by SCOP (red) and CATH 
(green).  
Domain numbers displayed in black indicate unambiguous domain assignments. Linear 
tri- and tetra- ubiquitin do not have PDB structures. Biliverdin reductase is comprised of 













Ubiquitin Bovine 8.6 1UBI 25% +34%  1 
Linear Di-Ubiquitin Human 17.1 3AXC 22% +33%  2 














27.3 1GTA 50% + 7%  2 





26.9 1GFL 10% + 49%  1 
Gamma D Crystallin Human 23.2 2G98 
9% + 42% 
　 
2 
Fibronectin III 8-10 Human 30.1 1FNF 51%  3 
K48 linked Di-
Ubiquitin 
Human 17.1 1AAR 19% + 34%  2 
K63 linked Di-
Ubiquitin 






Human 71.8 3QE2 36% + 20%  3 
Abelson Protein 
Tyrosine Kinase 
Human 33.2 2GQG 39% + 17%  1/2 
Transferrin Bovine 78.0 1BLF 31% + 17%  2/4 








Figure S. 4-1 Coulombic
unfolding data for proteins
discussed in the main text
of this chapter, including 1-
4 ubiquitins, 3 primarily -
helix proteins and 3
primarily -sheet proteins. 
CCS is plotted against
charge state adopted upon
solution unfolding. The
denaturing solution condition
used for each protein is listed
in the lower right corner of
each plot. Again, the number
of known domains in each
protein agrees with the
number of intermediate
stages, labeled A through D,
and equals the number of
unfolded conformational
families identified upon CIU,
labeled as I to V’. The most
compact structure of each
charge state is labeled using
closed circles. The
intermediate stages having
large CCS values are
characterized by multiple
unfolded structures that exist
simultaneously. These
intermediates, rather than the
most compact form, are




Figure S. 4-2 Collisional unfolding data of non-linear di-ubiquitins, K48 and K63 
linked, at charge states 7+ and 8+.  
No clear indication of a two-domain signature due to the sequence linkages that do not 
travel directly through the protein termini, although 8+ displays data with a signature 





Figure S. 4-3 Crystal structure (left), collisional unfolding (middle) and Coulombic 
unfolding (right) data for NADPH-Cytochrome P450 Reductase (CPR).  
This three-domain protein exhibits a clear three domain CIU pattern. On the other hand, 
the Coulombic unfolding data is more difficult to interpret.  Low intensity features for the 
final 2 domains, along with a higher degree of noise than expected, frustrate our analysis.  






Figure S. 4-4 Crystal structures (left), collisional unfolding (middle) and Coulombic 
unfolding data (right) for SCOP/CATH inconsistent proteins, Abelson protein 
tyrosine kinase and Transferrin.  
Abelson protein tyrosine kinase is assigned as a two domain protein by CATH (dark blue 
and light blue), however is considered a one domain protein in SCOP. Both collisional 
and Coulombic unfolding data indicate a 2-domain protein. We note, however, that the 
CCS peaks recorded for this protein during Coulombic unfolding are not as distinct as 
those found for proteins with unambiguous domain assignments. Transferrin, considered 
to have 2 distinct large domains with 2 subdomains in each, generates a collisional 
unfolding pattern that agrees well with CATH (4-domain protein), but a Coulombic 





Figure S. 4-5 Crystal structure (top, left), Coulombic unfolding (bottom left) and 
CIU (right) data of Biliverdin Reductase (BVR).  
Each domain of BVR consists of 2 sequence segments, according to CATH. However, 
these two domains are mixed, meaning that the part of the sequence for domain one 
overlaps spatially with domain two, and vice-versa.  The Coulombic unfolding data 
indicate a two-domain unfolding pattern. Nevertheless, both 10+ and 11+ ions subjected to 
CIU identify this protein as a having 3-domains, likely due to the inter-mingled nature of 
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Chapter 5. Applying IM-MS to Protein 
Complexes with Unknown Topology and 
Interface Structure 
5.1 Introduction 
To validate and extend the methods discussed in chapters 2-4 we have selected two multi-
protein systems with unknown structure to study in collaboration with researchers at the 
University of Michigan: the hetero-dimer of heme oxygenase-2 (HO-2) and NADPH-
cytochrome P450 reductase (CPR) in collaboration with the Ragsdale laboratory 
(Biological Chemistry Department), and a subcomplex from human mitochondrial RNase 
P (MRPP) in collaboration with the Fierke laboratory (Chemistry Department). Both of 
these systems have partial high-resolution structure data available, for instance the 
homotetramer of MRPP21,2 and the truncated version of HO-23 and CPR4,5 individually, 
but lack full sequence structural data that elucidates the arrangement of subunits within 
the larger complexes formed. Furthermore, the functional forms of both complexes are in 
the context of the complexes they create, rather than in their monomeric forms. As such, 
the structures of the intact complexes generated in both of these systems are essential for 
understanding the function of these complexes.  Here, we will apply the IM-MS methods 
discussed throughout this thesis in an effort elucidate such structures.  
142 
 
5.2 Studying the Heme Oxygenase-2 (HO-2) and NADPH-
Cytochrome P450 Reductase (CPR) interaction with IM-
MS 
5.2.1 Background Information about Heme Degradation 
Heme oxygenase (HO) is a membrane-bound microsomal enzyme that catalyzes the 
degradation of heme to biliverdin, carbon monoxide (CO), and free iron.6,7 Biliverdin is 
subsequently converted to bilirubin by a soluble cytosolic enzyme, biliverdin reductase 
(BVR).8 In this reaction, HO requires three molecules of oxygen and seven electrons 
supplied by NADPH-dependent cytochrome P450 reductase (CPR).6 CPR is a 78 kDa 
membrane-bound flavoprotein containing one FAD and FMN each.9 For electron 
transfer, CPR and its redox partners need to associate with each other.7,10  
Two principal isoforms of HO have been identified in mammalian cells, HO-1 and HO-
2.11 Both HO-1 and HO-2 exhibit similar catalytic properties; however, they are 
expressed at different locations in the body and have different modes of regulation. While 
HO-1 is induced under conditions of heat shock and oxidative stress conditions, and is 
present in most tissues, HO-2 is constitutively expressed in the brain, testes and carotid 
bodies.12 At the sequence level, HO-1 and HO-2 are highly homologous (55% identity, 
76% similarity).13,14 A significant difference in the sequence lies between residues 240-
295 (with respect to the HO-2 sequence). Thus far, HO-1 has been the more extensively 
studied of the two proteins, both structurally and biochemically. This dataset includes X-
ray structures of both the rat and human HO-1 in the heme-free15,16, heme-bound17,18, 
verdoheme-bound19, biliverdin-iron chelate-bound19,  and biliverdin-bound forms20. The 
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crystal structures of rat CPR and rat BVR have been also reported.4,5,21,22 HO-2 lacks 
much of the structural data currently available, with high-resolution data available only 
for truncated human forms of the protein available.3 The structures of HO-2 complexed to 
either CPR or BVR are completely unknown.  
The full length HO-2 contains 296 amino acids, with only 29-242 presented in the X-ray 
structure (PDB code: 2QPP), as the C-terminus is relatively unstructured after residue 
248. However, this C-terminal region is reported to contain two short amino acid 
stretches comprising a Cys-Pro dipeptide referred to as the heme regulatory motif 
(HRM),23 and is suspected to interact with CPR. Because of the obvious importance of 
the C-terminus of HO-2 in the context of heme regulation, we chose to work with a near-
full length HO-2 in the studies reported here, including residues 1-288. The last 8 amino 
acids are not included because their inclusion adversely affects the solubility of the 
protein due to their role in membrane association. Truncated forms of HO-2, including 
28-248 and 1-248 are also included in our studies in order to better evaluate the role of 
the C-terminus in CPR interactions. Also for solubility issues, the CPR construct studied 
here contains amino acids 69-680, removing the membrane associated N-terminus. 
Previous studies have shown that HO activity can be reconstructed with the soluble forms 
of HO and CPR.24 Below, we employ the approach developed in Chapter 3 of this thesis, 
automated titration coupled with IM-MS analysis, to quantify and evaluate the nature of 
the interactions between HO-2 and CPR. 
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5.2.2 Methods and Materials 
Three constructs of HO-2 (1-288, 1-248 and 28-248) and CPR were provided by the 
Ragsdale lab from the University of Michigan. The proteins exist primarily as monomer 
when sprayed separately. Heme-containing HO-2 was mixed with CPR in 100mM 
ammonium acetate (NH4Ac). The ratio between HO-2 and CPR was adjusted to optimize 
complex formation, eventually resulting in a 4:1 ratio at 20 M HO-2 and 5 M CPR for 
our experiments. The proteins were then titrated using a combination of DMSO and 
NH4Ac, followed by nESI using the nanomate Triversa (Advion, Ithaca NY, USA) for Q-
IM-MS analysis on a Synapt G2 (Waters, Milford MA, USA). For detailed accounting of 
the experimental methods used, see the experimental methods section of Chapter 3 of this 
thesis. 
Structure predictions for the HO-2 C-terminus were performed by the I-TASSER 
server.25 This online server allows for the high-quality prediction of 3D protein structure 
and biological function from amino acid sequence alone. After submitting an amino acid 
sequence, the server first tries to retrieve template proteins of similar folds from the PDB. 
Users can also manually submit PDB templates as restraints. After this, continuous 
fragments excised from the PDB templates are reassembled into full-length models by 
replica-exchange Monte Carlo simulations and by threading unaligned regions (mainly 
loops) built by ab initio modeling approaches. In cases where no appropriate template is 
identified from PDB inputs, I-TASSER builds the entire structure using ab initio type 
modeling. As a last step, a simulation is performed comparing the assembled protein and 
PDB structures in order to refine the global topology. The models generated in the second 
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simulations are then clustered and the lowest energy structures with optimized potential 
are selected.  
Simulated complex models shown here are generated by the ZDOCK server.26 ZDOCK 
searches all possible binding modes in the translational and rotational space between two 
target proteins. The exhaustiveness of this search is then evaluated using an energy-based 
scoring function for each contacting model discovered. The scoring function contains 
terms for the statistical potential, shape complementarity, and electrostatics of the protein 
complex. Further filtration of models in our experiments was performed manually by 
examining the heme-orientation, C-terminal contacts in the complex, and collision cross 
sections (CCS) of the models generated. 
5.2.3 Results and Discussion  
After mixing the heme-bound HO-2 1-288 with CPR in 100 mM NH4Ac, a complex 
between HO-2 and CPR is detected, having a stoichiometry of 1:1. Unlike the protein 
complexes studied in Chapter 3, HO and CPR are relatively weakly associated, as 
indicated by the relatively low signal intensity of the dimer relative to total ion current 
detected in the experiment, with about 18% of our recorded signal resulting from the 
intact complex. To study the interaction between HO-2 1-288 and CPR, we applied our 
2D titration approach, using NH4Ac and DMSO, to investigate the ability of these two 
disrupting agents to dissociate the HO-2/CPR dimer formed (Figure 5-1). As shown in 
Figure 5-1B, the intact complex signal intensity changes significantly as a function of 
NH4Ac concentration in solution, indicating the presence of some number of essential 
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polar contacts that stabilize the assembly. Unlike data shown in Chapter 3, where 
increasing amounts of DMSO in solution led to with increasing amounts of protein 
complex disruption, this assembly exhibits a tighter interaction with increasing DMSO up 
to 40% (by volume).  This stabilized complex, however, seems to completely dissociate 
at DMSO contents above 40%. A close inspection of the IM-MS data reveals that HO-2 
unfolds at solution conditions of 40% DMSO (Figure 5-1C) when compared to those with 
no DMSO added (Figure 5-1A), as indicated by the broadened IM features and higher 
charge states of the HO-2 monomers detected. This unfolded structure may contribute to 
the apparently-tightened interaction observed in our dataset. Because of the vulnerability 
of HO-2 to DMSO based unfolding, hydrophobic interaction between HO-2 and CPR 
could not been examined through our titration techniques. On the other hand, our NH4Ac 
based titration data collected at low DMSO concentrations reveals no evidence of 
unfolding, and the following discussion will focus on our attempts to mine such data to 
quantify the polar interactions between HO-2 and CPR.  
Following our Chapter 3 protocol, complex disruption as a function of NH4Ac 
concentration at a fixed DMSO content of 10% (indicated by white dashed line in Figure 
5-1B) can be effectively utilized to estimate the number of polar contacts that stabilize 
protein-protein complexes. As with our previous experiments, this amount of DMSO 
does not tend to unfold the proteins analyzed, but may disrupt local hydrophobic contacts 
enough to allow efficient disruption of buried salt bridges, focusing on polar contact only. 
Based on our previously-established relationship between NH4Ac and polar contacts 
found in X-ray structure of known complexes, derived in Chapter 3, a calibration curve 
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was constructed (Figure 5-2). By noting the NH4Ac concentration at which the HO-
2/CPR dimer signal drops by 10% relative to its intensity under native conditions (150 
mM) and by applying this experimental value to the calibration equation derived in 
Figure 5-2, the number of polar contacts, including salt-bridges and hydrogen-bonds, 
between HO-2 1-288 and CPR can be estimated to be 36, with a 95% confidence interval 
between 13 and 59 contacts.  
 
Figure 5-1 2D titration experiments on the HO-2+CPR complex.  
(A) IM-MS data collected at 200 mM NH4Ac without adding DMSO. (B) Percent of the 
signal corresponding to the intact HO-2+CPR complex plotted against DMSO and 
NH4Ac percent and concentration respectively, added in solution prior to nESI. (C) IM-
MS data collected at 200 mM NH4Ac and 40% DMSO.  Broadened features observed at 
low m/z and high IM drift times indicate the presence of unfolded protein. 
 
Further data were collected on the truncated HO-2 constructs 1-248 and 28-248, mixed 
with the same CPR protein, in 100 mM NH4Ac buffer. Both of these truncated HO-2 
forms generated 1:1 complexes with CPR, but with significantly lower signal intensities 
when compared directly to HO-2 1-288 (~5% signal intensity of the complexes recorded, 
13% less signal than observed with the longer HO-2 construct). A similar NH4Ac titration 
at fixed 10% DMSO as discussed above was performed for the HO-2 1-248/CPR 
complex and compared with our data for the longer HO-2 construct (Figure 5-3). The 
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significantly smaller starting ion intensity for the complexes comprised of truncated HO-
2, strongly indicates that the C-terminus of HO-2 is important for CPR binding. The N-
terminal truncated mutant, HO-2 28-248, forms similar amount of complexes (5%) with 
HO-2 1-248. However, this double-end truncated construct unfolds significantly at 10% 
DMSO, making similar IM-MS titration data as acquired for other HO-2 1-288/CPR 
complexes difficult to obtain. This observation, however, also indicates that the N-
terminus may be critically important in HO-2 protein stability overall, and is likely not 
critical for CPR binding. 
 
Figure 5-2 NH4Ac required for dissociation at 10% DMSO versus the number of 
polar contacts for both calibrants (black) and HO-2 1-288/CPR complex.  
(A) Two histogram plots generated for both calibrants and HO-2+CPR, with 
experimental data on top, and calculated data (either from X-ray or from calibration 
curve) on bottom. (B) Calibration curve for the protein complex disruption experiment, 
showing both calibrant points (black) and the unknown HO-2/CPR complex. The solid 
line represents the fitted linear trend and dashed lines report on the upper and lower 95% 
confidence interval (CI). The fitted linear equation for this experimental and calculated 





Figure 5-3 Titration experiment increasing the NH4Ac concentration at fixed DMSO 
content in solution for HO-2 1-288/CPR (black) and HO-2 1-248/CPR complexes 
(red). 
 
As the C-terminus, rather than N-terminus, is identified in our data as for a key element 
in HO-2/CPR complex formation, 3D structure prediction using I-TASSER was 
conducted to provide a model for residues 243-288, and dock this element to the crystal 
structure (residues 29-242). While the model generated for the C-terminus is docked in a 
range of disparate orientations and configurations in our top-scoring models (Figure 5-
4A), possibly due to the relatively unstructured and flexible nature of this section of the 
protein, the average model generated from these top-scoring candidates agrees well with 




Figure 5-4 HO-2 structures with predicted C-terminal (243-288).  
(A) The top 5 models predicted by I-TASSER aligned together, with color coded C-
termini from different models and a grey-colored core HO-2 (29-242). Heme is presented 
with blue and red spheres. (B) The average model generated by I-TASSER, with the C-
terminus (red) located in the center of the model. 
 
This averaged HO-2 29-288 model is then iterativlely docked onto CPR using a ZDOCK 
simulation. Figure 5-5 illustrates the docking search process for an optimzed complex 
model. After exhausting the binding modes between HO-2 29-288 (light green) and CPR 
(black) (Figure 5-5A), the ZDOCK ranks the complex models based on the ZDOCK 
scoring function, and filtered by our experimental constraints, which include heme 
orientation (physical proximity between heme and CPR is necessary for electron and 
oxygen transfer), HO-2 C-terminal contact with CPR, and CCS values for the intact 
complex. This final constraint has, in this case, the weakest ability to filter models when 
compared to the other physical constraints used here, because the CCS (an oreintationally 
averaged physical size for the complex) provides information only on the center-to-center 
distance of the interacting proteins and not their relative orientiation.  The combination of 





Figure 5-5 Docking simulation for optimized HO-2/CPR complex model using 
ZDOCK.  
(A) HO-2 (light green) docking searches for all possible binding modes with CPR 
(black). (B) The binding modes are evaluated by the ZDOCK energy scoring function 
and experimental constraints, save IM-MS titration data. (C) The number of polar 
contacts for high-scoring models compared against experimental predictions (pink 
region). (D) The single complex model with the number of polar contacts in closest 
agreement to experimental prediction.  
These optimized models are then filtered against the number of polar contacts present in 
the HO-2/CPR interface (Figure 5-5C). Note that the number of polar contacts found for 
all three models are within the 95% confidence interval predicted experimentally, but are 
in lower number region. This result is anticipated, as our current protein-protein docking 
protocol does not allow for flexible movement within individual proteins. Model 1 
(Figure 5.5D, green model) provides an HO-2/CPR model with polar contacts in closest 
agreement with our IM-MS titration data, having 26 total polar contacts. 
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5.3 Topology Construction for Constructing an IM-MS-
derived Topology for the Human Mitochondrial 
Ribonuclease P (RNase P) subcomplex 
5.3.1 Background Information on Human Mitochondrial RNase P  
Transfer RNA (tRNA) is a central adapter molecule during ribosome-dependent protein 
synthesis.27 Biosynthesis of mature functional tRNA requires extensive processing.27 The 
early steps for processing immature precursor tRNA (pre-tRNA) include the removal of 
extraneous sequences at the 5’ and 3’ termini by ribonucleases.28 The 5’ end maturation 
of tRNA is catalyzed by ribonuclease P (RNase P), a divalent metal ion-dependent 
endonuclease responsible for cleavage of the 5’ leader from pre-tRNA.29,30 In the 
bacterial, archaeal, and the eukaryotic nucleus, the endonuclease ribonuclease P (RNase 
P) is composed of a catalytic RNA that is assisted by protein subunits.31-34 Recently, 
human mitochondrial RNase P protein has gained attention as the catalytic activity of this 
enzyme derives entirely from proteins.35,36 This mitochondrial enzyme contains no RNA 
and consists only of three types of protein subunits mitochondrial RNase P proteins 1, 2, 
and 3 (MRPP1–3).37,38 None of the protein-only RNase P shares significant sequence 
homology with previous identified protein subunits in RNA-based RNase P.38 Such a 
dramatic variety in subunit composition makes RNase P, one of the most diverse 
enzymes in biochemistry, an exciting model system to directly compare RNA and protein 
based catalysis.38 Mutations in mtRNase P subunits and mitochondrial transfer RNAs 
(mt-tRNAs) have been implicated in a number of human diseases.1,2 Moreover, the 
majority of mt-tRNAs lack consensus sequences conserved for secondary and tertiary 
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structures in classic tRNA.39 Both human mtRNase P and mt-tRNAs are poorly 
characterized. 
Within the human mitochondrial Rnase P protein complex, MRPP2 has been crystallized 
and charaterized as a homotetramer.1,2 A homologous structure of MRPP3 has been 
resolved recently.40 Due to difficulties inheret in its expression and purification, MRPP1 
does not have an experiementally derived high-resolution structure. In addition, the 
stoichiometry of the subunits in the active MRPP 1:2:3 complex has not yet been 
established. Here, we describe the application of IM-MS, and the accurate CCS 
measurment approaches described in Chapter 2 of this thesis, to elucidate the structure 
and stoichiometry of the MRPP1:2 complex.  
5.3.2 Methods and Materials 
MRPP1 and 2 proteins were provided by the Fierke lab at the University of Michigan. 
Protein samples containing MRPP1 and 2 were ionized from 100 mM NH4Ac buffer 
solution by nESI. IM-MS data analysis converts the drifttime of each protein into CCS 
values using calibration curve. For details on the optimal instrument conditions for 
recording both unknown drift times and calibration curve data, refer to Chapter 2 of this 
thesis.  
CCS values for the subcomplexes and intact assemblies are then utilized as spatial 
restraints to build a complete 3D topology. CCS constraints are applied through the 
Integrative Modeling Platform (IMP), a python and C++ based toolbox for complex 
modeling, with each protein within the assembly represented as a course-grained 
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sphere.41 For topology optimization, candidate models are generated by an exhaustive 
search all of the possible  arragments of subunits given connectivity constraints defined 
by MS experiments. These models are then scored based on CCS, protein density, and 
symmetry based restraints.41,42  
5.3.3 Results and Discussions 
In addition to the homotetramer of MRPP2, both heterohexamers and heteropentamers 
comprised of MRPP1 andMRPP2 are observed by IM-MS when the proteins are mixed 
under native conditions and subjected to nESI (Figure 5-6A). Tandem MS using CID was 
carried on each population of subcomplexes observed to confirm their composition and 
stoichiometry (Figure 5-6B and C). This step is essential to precisly assign the intact 
mass of large protein complexes, as the primary MS data typically contain large amounts 
of buffer and adducts that skew mas measurments to higher values than expected from 
the sequences of individual subunits.43 The stoichiometry of the largest complex between 





Figure 5-6 Ion mobility-mass spectrometry (IM-MS) analysis of MRPP1·MRPP2 
complexes.  
(A) Three protein complex stoichiometries are observed, I: the homotetramer of MRPP2; 
II: a heteropentamer comprised of (MRPP1)1(MRPP2)4; III: a heterohexamer containing 
(MRPP1)2(MRPP2)4; (B) Tandem MS analysis for the MRPP2 homotetramer, showing 
only the monomer region the mass spectrum. (C) Tandem MS analysis of the 
heteropentamer (II) and heterohexamer (III), generating similar tandem MS data in the 
monomer region, confirming the presence of both proteins in the selected complexes. 
 
CCS values for the MRPP2 homotetramer are in good agreement of the expected CCS 
values for the complex (PDB code: 2O23). Since its structure is known, the MRPP2 
tetramer is set as a fixed core topology modeling shown here. In order to assign 
156 
 
connectivity to the MRPP1:2 complexes observed, detailed MS and IM-MS experiments 
were carried out. If the MRPP2 tetramer is analyzed in isolation by intact MS, small 
amounts of both monomer and dimer ion signal can be observed under native conditions 
(pH 7), strongly indicating a dimer of dimers arrangement. In contrast, isolated MRPP1 
does not form any oligomer observable by intact MS. As both heteropentamer and 
heterohexamer are observed by MS from solutions containing both MPRR1 and MRPP2, 
it is inferred that, in the heterohexamer, 2 MRPP1 bound to the MRPP2 homotetramer 
individually. Because of this, in the models generated here, contact between the two 
copies of MRPP1 is not prohibited, but this connection is also not input into the 
simulation as a constraint (Figure 5-7A). Symmetry is incorporated into our model as a 
second class of restraint, by setting the distance between each MRPP1 and the center of 
MRPP2 homotetramer to equal values. Using such a symmetry requirement for model 
generation, the top 500 models are selected. These models are then further filtered 
according to their CCS, with those models within 3% of experimental values collected 
and clustered for analysis (Figure 5-7B). Although small variations exist within each 
group, Figure 5-7C illustrates three groups of topologies that agree with all the spatial 
restraints described above. Of the three classes of structures shown in Figure 5-7, those 
that belong to the 'Boat II' cluster are most-likely to represent the native structure of the 
complex. Both the 'Planer' and 'Boat I' clusters have one MRPP2 contact per copy of 
MRPP2. Based on simple symmetry arguments, these complexes should be able to form 
homo-octameric complexes, for which we find no experimental evidence. In contrast, 
those structures that cluster well with the 'Boat II' structure are characterized by two 
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MRPP2 contacts per copy of MRPP1 in the complex, which predicts a hetero-hexameric 
assembly structure based on the arguments detailed above.  
 
Figure 5-7 Analysis of the modeling output for the MRPP1/2 heterohexamer.  
(A) Connectivity is input as the first spatial restraint. (B) Symmetry scores, CCS values 
for the heteropentamer and heterohexamer are used as second level of restraints. The red 
line indicates 3% CCS error relative to experimental results. (C) Generally, three groups 
of models generate both a reasonable symmetry score and CCS error (under the red line 
on B): Planar, Boat I and Boat II. 
 
5.4 Conclusions and Future Directions  
IM-MS experiments were performed to characterize the interactions within the interface 
of HO-2/CPR complexes, and this information was used to construct a model of the 
dimer formed. The number of polar contacts was estimated, and used along with MS data 
indicating a strong involvement of the C-terminus of the HO-2 protein in the interaction, 
to generate models. Overall, these data, along with various other restraints, were used to 
create a putative contact model between HO-2 and CPR. Despite the fact that MS of 
intact proteins typically provides 'global' constraints for such models, the data here 
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provides complimentary 'local' information for model generation, and was vital in 
filtering models generated in rigid docking simulations.  
In a second example, IM-MS was applied to determine the stoichiometry and architecture 
of the MRPP1/2 complex. The stoichiometry of the largest complex between MRPP1 and 
MRPP2 observed in our experiments was determined to be 2:4 using both intact MS and 
tandem MS experiments. Potential topologies were determined using spatial restraints 
derrived from CCS values and symmetry, primarily. The most-likely models generated 
contain two MRPP2 contacts for every MRPP1 in the complex, thus rationalizing the 2:4 
hetero-hexamer stoichiometry measured in our experiments. 
While the models described in this chapter are best-described as preliminary, they 
provide excellent starting points for further experiments that seek to provide additional 
local constraints on the details of the protein-protein contacts in these systems. For 
example, detailed protein-protein interaction sites can be mapped by HDX, oxidative 
labeling and chemical crosslinking experiments combined with MS. Further, integrative 
modeling combining other low-resolution techniques, such as EM, would be highly 
beneficial to valdiate some of the models discussed here. 
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Chapter 6. Conclusions and Future Directions 
6.1 Conclusions 
IM-MS is an emergent technology for structural proteomics, capable of assessing 
multiprotein topologies from complex mixtures using minute amounts of sample.1,2 
Computational analysis is a key aspect of IM-MS data interpretation, and developments 
in this area are likely to be rapid over the next five years.3 The goal of this thesis is to 
develop protocols that overcome the current challenges in IM-MS experiments aimed at 
characterizing multiprotein topology and protein interfaces.  Like early experiments in 
high-throughput X-ray structures for proteins, robot-assisted IM-MS is seeking for 
optimal experimental conditions from a vast array of potential solution states. Detailed 
subunit sizing and interface properties are revealed by mapping the solution conditions 
involved.  Further, gas-phase and solution-phase unfolding enhance the capabilities for 
assessing three-dimensional protein architecture, by refining the topology construction to 
domain level. The number of domains with in single protein subunit could be the key for 
accurate topology modeling and also assess the intra-chain flexibility. However, 
challenges remain when apply these protocols to unknown protein systems. The analysis 
of multiprotein complexes of unknown composition requires integration of intact IM-MS 
measurements with ‘top-down’ and ‘bottom-up’ style proteomics workflows in order to 
correctly derive protein connectivity and topology. Two major trends could be involved 
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in the future application of these protocols: the first is to refine the protocols even more 
with smaller and simpler systems to accurately assess the basic mechanism behind of gas-
phase and solution phase disruption; The second is to take advantages of these protocols 
for the structural characterization of unknown protein systems, in combination of other 
techniques, i.e. EM, HDX and crosslinking.  
6.2 Future Directions 
6.2.1 Refine Protein-Protein Interface Study with Defined Protein 
Complexes 
In chapter 3, we established a strong correlation between the nature/concentration of 
chemical disrupting agents in solution and the chemical properties of the protein-protein 
interfaces. However, large error bars, or in other words, less precision is achieved for 
interface prediction using this correlation, especially when salt bridge interactions are 
considered. We attribute this lack of precision to the fact that the responses of the protein-
interactions.to ammonium acetate and dimethyl sulfoxide are not perfectly orthogonal. In 
addition, the flexibility of protein structures may also allow long-distance salt-bridge 
interactions to be accessed during the disrupting process that are not present in the native 
structure.4,5 To better understand the solution disruption of multiprotein complexes, and 
also to push the accuracy/precision of the method presented in chapter 3, experiments 
should be performed on systems of reduced complexity, constructed from rigid 
biopolymer systems where models of protein-protein interfaces can be designed in detail. 
For instance, tailored leucine zipper interfaces6 and amphipathic helix dimers7 are two 
systems that fulfill the above criteria, both having protein structures and interfaces well-
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defined, minimally influenced by hydrophobic packing forces. In addition to providing 
experimental measurements that may lead to high accuracy/precision salt-bridge 
quantitation in unknown protein interfaces, it is likely that experiments on such small 
helix-helix interactions will provide important calibration points for the method presented 
in chapter 3.  Such experiments should eventually lead to a broader set of data collected 
over a very broad range of protein complexes, in an effort to develop an exhaustive 
protein disruption database covering a greater number of protein structure motifs than 
presented currently in chapter 3.  
6.2.2 Extend the Application on Assemblies with Unknown 
Architectures, with the Assistance from other Techniques 
 In parallel with the work described above, other complimentary MS-based tools capable 
of protein interface foot-printing should be integrated with protein complex disruption 
experiments.  For example, HDX, oxidative labeling, and chemical crosslinking-MS data 
should be compared with the method presented in chapter 3, evaluating the ability of each 
to define the regions of protein interaction and the chemical properties of those contacts. 
By combining all types of MS-related data listed above, higher accuracy protein complex 
models may be generated.  
Examples from chapter 5, including the HO-2+CPR and RNase P systems, should be 
early systems targeted by the experiments described above. Furthermore, integrated MS 
analysis can also be applied to more complicated protein assemblies than those shown in 
chapter 5, including the urease activation complex shown in Figure 6-1. This assembly 
consists of 18 subunits with 3 folds symmetry, and has been the subject of intact MS 
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analysis previously8. There are two possible mechanisms for the complete assembly of 
the urease activation complex, and can be differentiated by the topology and connectivity 
of the intermediate complexes detected during MS analysis. Our preliminary data9 
suggests an activation mechanism that agrees more-closely with the lower path shown in 
Figure 6-1. Accurate topologies of the intact complex and associated subcomplexes are 
crucial in understanding the activation mechanism operative in cells. 
 
Figure 6-1 Simulated working model of urease activation.  
The urease apoprotein (orange UreA, sand UreB, and yellow UreC) sequentially binds 
UreD (green), UreF (magenta), and UreG (cyan), or binds a complex of these three 
accessory proteins to form a pre-activation complex. Synthesis of active enzyme requires 
carbamylation of an active site lysine by CO2, GTP hydrolysis by UreG, and Ni
2+ transfer 
from the UreE metallochaperone. Structures of the docked complexes are derived from 
computational models. UreD, UreF and UreE structures are adapt from homologous 
proteins. 
 
On the other hand, integrative structural biology that includes data beyond MS is likely to 
be main route for determining high-resolution structural models for currently unknown 
protein complexes. MS, combined with data from X-ray crystallography, NMR 
spectroscopy, cryo-EM, and SAXS, could generate a comprehensive analyses of large, 
dynamic, macromolecular machines that incorporates many levels of structural 
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information.10-12 Such “hybrid approaches”, will undoubtedly require further 
developments in bio-informatics and software, which will likely be a focus of many 
active research groups in the near future. For the scope of the examples shown in this 
thesis, the RNase P complex discussed in chapter 5 would be an excellent target for such 
experiments, especially those that combine EM and IM-MS data. 
6.2.3 Antibody Disulfide Mapping 
Antibodies are broadly-important in biotechnology, disease, and biophysics13,14. 
Pharmaceutical companies are interested in developing methodologies to quickly 
determine if an antibody produced during scaled-up procedures is identical to those 
generated in control experiments, especially in terms of their disulfide connectivity15-19. 
Many years ago, MS-based protocols were developed for disulfide mapping that involve 
proteolysis followed by tandem MS20. While powerful, this approach is slow and labor-
intensive. Preliminary data for IgG1, shown in Figure 6-2, indicates that different CIU 
patterns likely develop for intact heavy chains in different disulfide bound states. Further 
experiments should seek to validate the differences shown in Figure 6-2 for systems 
where the disulfide patterns are known precisely, and evaluate this approach for systems 




Figure 6-2 Collisional unfolding data of IgG heavy chain, with intact disulfide bonds 
or reduced disulfide bonds.  
These two datasets display significantly different structural features derived from samples 
with or without intact intra-molecular disulfide bonds. The disulfide-reduced heavy chain 
has a low energy structure that is larger than disulfide intact, and extends into 
significantly more unfolded intermediates and final structures than the disulfide intact 
version. As these datasets are acquired from identical charge states, and under the same 
instrument conditions, this difference is best interpreted as being related to presence or 
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